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ABSTRACT OF THE DISSERTATION
MOVEMENT EFFECTS ON THE FLOW PHYSICS AND NUTRIENT DELIVERY
IN ENGINEERED VALVULAR TISSUES
by
Manuel Salinas
Florida International University, 2015
Miami, Florida
Professor Sharan Ramaswamy, Major Professor
Mechanical conditioning has been shown to promote tissue formation in a wide
variety of tissue engineering efforts. However the underlying mechanisms by
which external mechanical stimuli regulate cells and tissues are not known. This
is particularly relevant in the area of heart valve tissue engineering (HVTE) owing
to the intense hemodynamic environments that surround native valves. Some
studies suggest that oscillatory shear stress (OSS) caused by steady flow and
scaffold flexure play a critical role in engineered tissue formation derived from
bone marrow derived stem cells (BMSCs). In addition, scaffold flexure may
enhance

nutrient

(e.g.

oxygen,

glucose) transport. In this study, we

computationally quantified the i) magnitude of fluid-induced shear stresses; ii) the
extent of temporal fluid oscillations in the flow field using the oscillatory shear
index (OSI) parameter, and iii) glucose and oxygen mass transport profiles.
Noting that sample cyclic flexure induces a high degree of oscillatory shear
stress (OSS), we incorporated moving boundary computational fluid dynamic
simulations of samples housed within a bioreactor to consider the effects of: 1)

iv

no flow, no flexure (control group), 2) steady flow-alone, 3) cyclic flexure-alone
and 4) combined steady flow and cyclic flexure environments. We also coupled a
diffusion and convention mass transport equation to the simulated system. We
found that the coexistence of both OSS and appreciable shear stress
magnitudes, described by the newly introduced parameter OSI-| |, explained the
high levels of engineered collagen previously observed from combining cyclic
flexure and steady flow states. On the other hand, each of these metrics on its
own showed no association. This finding suggests that cyclic flexure and steady
flow synergistically promote engineered heart valve tissue production via OSS,
so long as the oscillations are accompanied by a critical magnitude of shear
stress. In addition, our simulations showed that mass transport of glucose and
oxygen is enhanced by sample movement at low sample porosities, but did not
play a role in highly porous scaffolds. Preliminary in-house in vitro experiments
showed that cell proliferation and phenotype is enhanced in OSI-| |
environments.
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CHAPTER 1: INTRODUCTION
Heart valve disease is a major health care concern around the world. It is
estimated that over 290,000 damaged heart valves are replaced with prosthetic
valves annually, and it is expected to triple in the next four decades (Gandaglia et
al., 2011). Native heart valves (NHVs) are multilayered highly adaptable and
highly regulated structures. NHVs open and close nearly three billion times over
the time course of the average human lifespan, and its motion is driven by
surrounding hemodynamic forces (Schoen, 2008). NHVs are subjected to
complex time-varying stresses due to combinations of flow, stretch and flexure
(FSF), and their closing is aided by flow vortices behind the cusps on the arterial
side (Schoen, 2008). NHVs are tightly regulated with continuous tissue
remodeling activity capable of adapting to different hemodynamic loads
(Kleinstreuer, 2006).
The use of prosthetic heart valves substantially restores valve
functionality. However, mechanical heart valves (MHVs) may result in hemolysis
and possible platelet activation due to abnormal hemodynamics (Ratner et al., ).
Similarly, biological heart valves (BHVs) can fail due to calcification and immune
rejection (Kleinstreuer, 2006; Silverthorn, 2005). Other emerging techniques such
as polymeric substitutes need to be further evaluated. Heart valve tissue
engineering aims at the development of an in vitro implant with similar
mechanical properties and anatomy as native valves. Moreover, a primary goal
of this approach is to promote engineered tissue remodeling and growth
(Ramaswamy et al., 2008). However, no long term/ perpetual reliable engineered
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valve has been obtained thus far due to the complexity in mimicking the
environments that native valves are exposed to (El-Hamamsy et al., 2010;
Gandaglia et al., 2011; Sutherland et al., 2005). The use of computational fluid
dynamics (CFD) has provided with insights on these complex time varying flow
environments that NHVs are exposed to, but complete and exhaustive data from
dynamic simulations are still needed today as well as simulation data correlation
to experimental findings. The objectives of this proposal are to study the effects
of valve-like movement on resulting fluid-induced stresses and mass transport
efficiency (Oxygen and glucose) in developing engineered heart valve tissues.
Our underlying hypothesis is that specimen movement effects will result in
heighted, fluid-induced, oscillatory shear stresses on the specimens as well as
an enhancement in the mass transport of key gas and nutrient species to the
developing heart valve tissues. We will test this hypothesis by carrying out the
following specific aims:
2

Specific Aims

Aim 1: Identify fluid-induced shear stress, velocity, and oscillatory
stress distributions on engineered tissue specimens during valve-like
deformations.
Valve-like movement introduces spatial and time varying effects that may be
important for the development of tissue engineered heart valve (TEHV)
constructs. We will perform specimen dynamic and static steady state CFD
simulations, and we will evaluate the flow physics surrounding the constructs.

2

Aim 2: Quantify oxygen and glucose concentration profiles on
engineered tissue specimen geometry during valve-like deformations.
Valve-like movement produces varying velocities and pressures around and
within the sample. This may aid in the flux of nutrients (glucose and oxygen)
through the walls and into the cells and tissue. With data from the dynamic
simulations, we will determine if specimen movement improves mass transport
of 1 gas (oxygen) and 1 nutrient species (glucose) through the constructs.
Aim 3: Co-relate findings derived from aims 1 and 2 to supporting
experiments on engineered tissue formation under static and dynamic
tissue culture states, specifically engineered collagen production by the
scaffold-seeded, bone marrow derived, mesenchymal stem cells.
Spatially and t i m e varying fluid-induced stresses and mass transport (Oxygen
and glucose) effects may improve t i s s u e formation i n T E H V constructs but
the underlying mechanisms yielding this improvement are not known. To
provide further insights on this process, we will c o m p a r e t r a n s p o r t
phenomena-related data from the simulations (aims 1 and 2) with collagen
assay exp er im ent al data obtained from the literature.

3

CHAPTER 2: HEART VALVES ANATOMY, DISEASE AND PROSTHETIC
DEVICES
2.1

Heart Valves
Healthy heart valves are essential for proper blood circulation. Their role is

to ensure uni-directional blood flow in the circulation. They consist of different
tissue layers and are capable of adapting and remodeling their tissue
composition according to the hemodynamic environments surrounding them
(Waterbolk et al., 2006; Westhoff-Bleck et al., 2011; Zilla et al., 2008). The mitral
and tricuspid valves are located between the atria and ventricles while the
pulmonary valve is found intersecting the right ventricle and the pulmonary
artery. The aortic valve resides between the left ventricle and the aorta.
When blood enters the heart through the vena cava into the right atrium, it
creates an increase in intra-chamber pressure. When the right atrial pressure
exceeds the pressure in the right ventricle, the tricuspid valve opens thereby
allowing blood to flow into the right ventricle. Simultaneously, the mitral valve
also opens and permits blood to flow from the left atrium into the left ventricle.
When the right ventricular pressure exceeds the pressure of the pulmonary
arteries, the pulmonary valve opens, allowing blood to flow towards the lungs
permitting exchange of oxygen and carbon dioxide. Concurrently, the aortic valve
allows oxygen-rich blood to flow to the aorta and towards systemic organs and
tissues. It closes once the pressure in the aorta exceeds the ventricular pressure.
Over the course of the average human lifespan, native heart valves
(NHVs) open and close an estimated three billion times (Schoen, 2008). During
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each heartbeat, they are subjected to different hemodynamic loads in the form of
flow, stretch and flexure (Ramaswamy et al., 2010; Salinas et al., 2014a; Salinas
et al., 2014b). In past decades, NHVs have been thought to be passive
structures. However, recent studies have shown tremendous cell and tissue
activity occurring on its surface and within its layered structure (Ramaswamy et
al., 2010; Sacks et al., 2009a; Sacks et al., 2009b; Salinas et al., 2014a; Salinas
et al., 2014b).
2.2

Heart Valve Disease
For simplicity, we refer from this point forward to any aberrant condition

caused by anomalous structures and/or disease manifestation on heart valves as
heart valve disease (HVD). HVD can be caused by immune disorders, trauma to
the valve or surrounding tissues, hypertention, degenerative valve calcification,
endocarditis, rheumatic fever and by congenital birth defects (Bernard, 2008; Dal
Pan et al., 2005; Elkayam and Bitar, 2005; Frederick J., 2006; Iyengar et al.,
2004; Lorna, 2010; Mohammadi and Mequanint, 2011; Neuenschwander and P.
Hoerstrup, 2004; Shahbudin H., 2010; Siu and Silversides, 2010; Talwar et al.,
2005; Waterbolk et al., 2006; Westhoff-Bleck et al., 2011). It can be diagnosed by
listening to the opening and closing of the valves through a stethoscope for the
identification of heart murmurs. Other methods of detection include
echocardiography, electrocardiogram, chest X-ray, cardiac catheterization, stress
testing, or magnetic resonance imaging (Elkayam and Bitar, 2005; Iyengar et al.,
2004; Lorna, 2010; Siu and Silversides, 2010; Talwar et al., 2005).
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Common symptoms of HVD include aortic valve regurgitation, wherein
one or more of the three leaflets do not close properly, thereby causing blood to
flow back through the valve into the left ventricle (Baig and Punjabi, 2008;
Bernard, 2008; Dal Pan et al., 2005; Elkayam and Bitar, 2005). When
regurgitation fractions are large, the left ventricle will overwork to pump more
blood out of the heart, which may result in left ventricular hypertrophy and
possibly heart failure, if left untreated. Another condition, aortic valve stenosis is
a state in which the valve leaflets become stiff or even fuse together resulting in
narrowing of the aortic valve (Shahbudin H., 2010; Talwar et al., 2005; Waterbolk
et al., 2006). This in turn causes a reduction in the valve orifice area which
exhibits disturbances in the normal hemodynamics (Iyengar et al., 2004; Lorna,
2010; Mohammadi and Mequanint, 2011; Siu and Silversides, 2010; Talwar et
al., 2005; Waterbolk et al., 2006; Westhoff-Bleck et al., 2011). Valve stenosis
can be congenital or be caused later in life due to, for example, onset of
calcification of leaflets. Importantly, the workload on the left ventricle increases
considerably which can result in serious complications, as mentioned previously.
2.3

Valve Prosthetics and Substitutes

2.3.1 Mechanical Valves
Mechanical heart valves (MHV) are prosthetic devices made out of high
strength, artificial materials such as titanium and pyrolytic carbon (Mohammadi
and Mequanint, 2011; Shahbudin H., 2010; Sotiropoulos and Borazjani, 2009).
The most common MHV designs include the ball and cage, tilting disk, and the
bileaflet (Butcher et al., 2011; Gandaglia et al., 2011; Shahbudin H., 2010; Zilla et
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al., 2008) mechanical heart valve. The bileaflet design (e.g. bileaflet valve from
St. Jude Medical) is currently very popular because of its superior
hemodynamics, such as the ability to exhibit low transvalvular pressure gradients
(Lorna, 2010; Mohammadi and Mequanint, 2011; Shahbudin H., 2010).
Open

Closed

Mechanical

Bileaflet

Tilting disk

Ball and cage

Bio-prosthetic

Figure 1. Mechanical and Biological Heart valves.
MHVs have shown to be reliable and long lasting. However, there are
some serious limitations that tend to exclude several segments of the population
affected by severe HVD. One problem is a predisposition to hemolysis and
platelet activation which can trigger thrombus nucleation that could potentially
cause blood flow disturbances (Arcidiacono et al., 2005; David and Hsu, 1996a;
David and Hsu, 1996b). Furthermore, blood clots could potentially separate from
the valve surface and cause a stroke if the clot migrates to the vasculature in the
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brain. Anticoagulation therapy (e.g. heparin) is required for as long as the MHV
is implanted. The use of MHVs are mainly suggested for adults and are not
recommended for young children who are prone to injury, women who wish to
have children, individuals who cannot tolerate anticoagulation medication (e.g.
heparin) and other sub-population groups who are at risk for traumatic episodes
of bleeding (Baig and Punjabi, 2008; Talwar et al., 2005).
2.3.2 Bio-prosthetic Valves
Bio-prosthetic valves (BPVs) are created by forming the native tissue
found in animals (Neuenschwander and P. Hoerstrup, 2004; Sha, 2010) into a
valve-shaped construct. Sources of animal tissue include the porcine aortic valve
and the bovine pericardium (Neuenschwander and P. Hoerstrup, 2004; Zilla et
al., 2008). BPVs offer superior hemodynamics over any mechanical valve
including the bileaflet design. However, they are pre-disposed to leaflet
calcification and early structural breakdown (Ramaswamy et al., 2010; Salinas et
al., 2014a; Salinas et al., 2014b).
Homografts, derived from human cadavers serve as allografts
(Anastasiadis et al., 2004; Shahbudin H., 2010). The first aortic valve
replacement with a homograft occurred in 1962 by Ross (Ungerleider et al.,
2010). These substitutes do not pose a risk of coagulation problems thereby
eliminating the need for anticoagulation therapies (Anastasiadis et al., 2004).
Other advantages include an absence of hemolysis, very good hemodynamics,
good implant integration, resistance to infection and a low trans-valvular pressure
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(Anastasiadis et al., 2004; Shahbudin H., 2010). However homografts are also
calcification prone and are very limited in supply.
2.3.3 Autografts
Valve autografts are valve implants wherein a pulmonary valve is
dissected and secured in the aortic position to compensate for a malfunctioning
aortic valve. Meanwhile a homograft is implanted in the pulmonary artery to
substitute for the native valve that is removed. This process, clinically known as
the Ross procedure has demonstrated extensive benefits (Athanasiou et al.,
2004; Brown et al., 2004; Gamez et al., 2011; Jaggers et al., 1998; Khwaja et al.,
2005; Pretorius et al., 2008; Rus et al., 2004; Sarioglu et al., 2003; Slater et al.,
2005; Stelzer, 2011; Ungerleider et al., 2010) such as: i) no necessity for lifelong
coagulation therapy, ii) minimal risk of calcification, iii) durability, iv) minimal
scaring, v) adequate hemodynamics, vi) growth potential and vii) a low risk of
infections and tissue rejection. However, the critical shortcomings (Brown et al.,
2004; Gamez et al., 2011; Jaggers et al., 1998; Khwaja et al., 2005; Pretorius et
al., 2008; Rus et al., 2004; Sarioglu et al., 2003; Slater et al., 2005; Stelzer, 2011;
Ungerleider et al., 2010) that restrict this approach are that it: i) requires a high
level of technical skill from the surgeon, ii) data to support long-term outcomes is
limited, iii) homograft in pulmonary circulation will likely require replacement over
human lifetime, iv) it cannot be used in children with structural abnormalities on
their pulmonary valve (due to Marfan syndrome, systemic lupus erythematosus
and juvenile rheumatoid arthritis).
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2.3.4 Emerging technologies
2.3.4.1 Polymer valves
Development of polymer heart valves were investigated several years
ago. However, the main challenge presented at that time was material durability,
and this caused an abandonment of these technologies (Ghanbari et al., 2009).
Recently, this area of research has been revisited due to more advanced state of
the art polymer manufacturing technologies and the development of stronger,
biocompatible polymers and polymer composite materials (Di Martino et al.,
1997; Ghanbari et al., 2009; Kidane et al., 2009; Ramaswamy et al., 2013).
There is also a need for developing valve substitutes that can be integrated with
minimal invasive techniques, such as percutaneous valve technologies, which
polymer valves are thought to be able to meet (Ramaswamy et al., 2012;
Shahbudin H., 2010; Vyavahare et al., 1997).
Polymeric implants can be produced in large quantities and in multiple
sizes with low manufacturing cost. The polymers of preference are highly
biocompatible elastomers that can be formed to resemble valve-like structures
and are able to mimic the deformation of native valve leaflets (Ghanbari et al.,
2009; Kidane et al., 2009). However much needs to be done in development to
ensure that these types of valves are durable long-term and this remains a
subject of on-going research. To date, no polymer valve implant has been
approved by the FDA. A critical limitation of polymer valves even if thrombosis,
calcification, lack of functionality and weak structural properties can be overcome
is that they cannot account for somatic growth in children who have severe HVD;
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in other words, the replacement valve cannot grow and remodel with the overall
growth of the child. This means that multiple surgical procedures will still be
needed for the pediatric patient with severe congenital HVD.
2.3.4.2 Tissue Engineered Heart Valves
The purpose of heart valve tissue engineering is to obtain an in vitro graft
with mechanical properties and anatomical-like structures similar to those of
native valves as well as to accommodate somatic growth (Martinez et al., 2013;
Ramaswamy et al., 2010; Salinas et al., 2014a; Salinas et al., 2014b). This can
be potentially achieved by seeding biomaterial scaffolds with autologous cells
such as bone marrow derived stem cells (BMSCs) (Kadner et al., 2002; Leor et
al., 2005; Perry et al., 2003; Ramaswamy et al., 2010; Salinas et al., 2014a;
Salinas et al., 2014b) and subjecting them to mechanical conditioning paradigms
until sufficient heart valve cells and tissue growth in vitro has been achieved
(Ramaswamy et al., 2014). Suitable cell sources for tissue engineered heart
valves (TEHVs) are primary endothelial (ECs) and smooth muscle cells (SMCs)
from a vein that can be harvested without compromise to the vasculature (e.g.
saphenous vein in the leg) (Schmidt et al., 2010; Siepe et al., 2008) as well as
progenitor cells sources such as periodontal ligament cells (PDLs) derived from
wisdom teeth (Huang et al., 2009). Stem cells such as bone marrow derived
stem cells (BMSCs) offer the advantage of being obtained in a much less
invasive approach and are accessible whenever needed (Engelmayr et al., 2006;
Ramaswamy et al., 2010).
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Figure 2. Tissue Engineering Approach
In terms of the scaffolding components, common biodegradable polymers
such as polylactic acid (PLA), polyglycolic acid (PGA) and blends or co-polymers
of these two materials, e.g., a 50:50 blend (by weight) of PGA:PLLA nonwoven
fabric or poly( lactic-co-glycolic acid), PLGA, have been utilized for heart valve
tissue engineering purposes because of their biocompatibility and biodegradable
properties (Chen and Wu, 2005; Fong et al., 2006; Leor et al., 2005). However,
as cell sources are being identified and as mechanical conditioning protocols are
being optimized, it is also critical to at the same time tailor scaffold properties that
will demonstrate resilience to cyclic tensile, bending and fluid-induced stress
states, while still permitting adequate levels of opening and closing dynamics
(Chen and Wu, 2005; Fong et al., 2006; Leor et al., 2005). In this regard,
scaffolds made of decellularized animal valves have been utilized (Lichtenberg et
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al., 2006), but unfavorable interactions between the colonizing cells and tissue
proteins such as collagen have persisted (Gandaglia et al., 2011; Kleinstreuer,
2006). Recent work has also focused on the idea of using elastomeric
substrates that can recapitulate native valve deformation (Ramaswamy et al.,
2010; Salinas et al., 2014a; Salinas et al., 2014b). Many challenges need to yet
be overcome in optimizing in vitro grown TEHVs that are capable of withstanding
in vivo hemodynamic environments and concomitantly permitting growth and
tissue remodeling. These technical barriers need to be addressed in order to
bring TEHVs from its current research state to that of clinical reality (El-Hamamsy
et al., 2010; Gandaglia et al., 2011; Sutherland et al., 2005).

CHAPTER 3: COMPUTATIONAL FLUID DYNAMICS AND ITS APPLICATIONS
IN HEART VALVE STUDIES
Heart valves are subjected to a complex hemodynamic environment. The
loading states on native valves during healthy, diseased, pre and post-surgical
interventional states as well as prosthetic valves and emerging technologies (e.g.
tissue engineered heart valves) can be delineated using computational predictive
models. In turn, several insights on how these results may translate to long term
functionality can be made. In this context, computational fluid dynamic (CFD)
and finite element (FE) model development in the heart valve arena remain a
vibrant area of research. FE models are generally applied to evaluate solid
surface strains due to cyclical stretching and bending. On the other hand, CFD
models examine the effects of fluid induced stresses on the leaflet surfaces. In
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this chapter we focus on CFD models. However we also present fluid structure
interaction approaches (FSI) which essentially combines both CFD and FE
approaches to delineate both the fluid and solid mechanical responses of the
leaflets.
CFD processes for heart valve analyses are based on two numerical
methods: The finite element method (FEM) and finite volume method (FVM)
(Krause, 1985; Peskin, 1972; Peskin and McQueen, 1980). Both of these
techniques subdivide the flow domain into a large number of finite entities,
elements, in the case of the FEM, and control volumes, in the case of FVM
(Krause, 1985; Peskin, 1972; Peskin and McQueen, 1980). Later, an iterative
method is used to obtain the solution for each spatial element or volume. The
overall goal is to solve the governing equations of the fluid given by the 3dimensional (3-D) Navier-Stokes equations, by simplifying large complex partial
differential equations for the flow physics into algebraic equations (Hose et al.,
2006; Onate et al., 2004; Storti et al., 2008). Through this approach, CFD can
numerically predict a solution for the nonlinear Navier-Stokes equations which
allows the uncovering of the blood flow field surrounding a heart valve (Chandran
et al., 2007; Kleinstreuer, 2006).
The usage of CFD to study heart valves can be traced back to the early
1970s. The first models accounted only for 2-dimensional (2D) analysis with
oversimplified geometries. 3D models were constructed several years later in the
late 1980s and early 1990s. We summarize some important milestones in CFD
of heart valves and heart valve prostheses here: The flow through a tilting disk in
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a permanently half open position was simulated using a FEM approach by Shim
and Cham (Shim and Chang, 1994). Ge et al. (Ge et al., 2005; Ge et al., 2003)
performed computer simulations for mechanical valves at Reynolds numbers
(Re) describing laminar and turbulent flow; specifically at Reynolds numbers of
750 and 6,000 respectively. The leaflets of this simplified valve were fixed at a
completely open state. McQueen et al. (McQueen and Peskin, 1985) described
how computer modeling can be used to study design criteria in bileaflet valves
with flat and curved leaflets. Lei et al. (Lei et al., 1992) developed a 2D flow
model around a Björk-Shiley tilting disk valve under steady state conditions.
Simultaneously, Lei et al. (Lei et al., 1992) conducted laser Doppler anemometry
(LDA) on a experimental Björk-Shiley tilting disk valve setup that used a mixture
of oil and kerosene as the fluid. However, helical vortices observed in the
experimental data could not be predicted through the computational results.
Kiris et al. (Kiris et al., 1997) focused on flow past a tilting disk in a fixed
position of 30 degrees while ranging Re between two and six thousand. This
study used a FVM and solved the 3D Reynolds-averaged Navier-Stokes (RANS)
equations that also accounted for turbulence. King et al. (King et al., 1996)
described the presence of orifice jets during systole velocities in a CarboMedics®
valve. The jet regions were observed to merge towards the aortic walls, and
there was evidence of jets in the central flow downstream of the valve leaflets.
Experimental results from this study by means of flow visualization and LDA
reasonably supported these observations.
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King et al. (King et al., 1997) used a commercially available FEM based
software called FIDAP (Fluent, Lebanon, NH) to simulate a simplified one-quarter
model of a fixed valve at a Re = 1500. Different leaflet opening angles were
used, and it was shown that downstream flow became more centralized and
maximum velocity and maximum shear rate increased as well.
3.1 General CFD steps
Presently, there are a wide variety of commercially available software
packages such as CFX ® (Ansys, Canonsburg, PA), CFD-ACE ® (ESI Group,
France), COMSOL® (Burlington, MA), FLEX PDE® (Scientific Software Solutions
Int, GR - Europe ), FLUENT ® (Ansys, Canonsburg, PA), etc. The operating
stages of any of these software packages can be described in three basic steps:
pre-processing, solving, and post-processing. The pre-processing stage deals
with the construction of geometry; meshing parameters such as grid type and cell
size; boundary conditions for all inlets, outlets, walls and interfaces, coupling of
equations, and incorporation of physical, mechanical and chemical properties (if
needed) into the system. The solving stage involves the setting up of the
numerical model, selection of the right solver, and monitoring the computed
solution. The post processing stage mainly deals with the creation of 2-D and 3-D
plots as well as videos in order to present and interpret the results. If general,
revisions and updates to the model will need to be done if the results are
erroneous due to lack of numerical accuracy. As a result, a large part of the
modeling process will require validation of the computational results with a
corresponding experiment.
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3.2 Moving Boundary Problems
Presently, simulations involving moving interfaces between flowing or
deforming media are some of the most challenging problems in computational
science (Driessen et al., 2007; Nobili et al., 2008; Vierendeels et al., 2008). In
the body, the movement of heart valves represents an active, dynamic system
(Gilmanov and Sotiropoulos, 2005; Peskin, 1972). From a modeling perspective
the challenges are linked directly to the numerous differential equations that need
to be satisfied for different components within the system (e.g. blood, vessel wall,
moving leaflets, etc.), and that these solutions need to also be satisfied through
mathematical relationships and appropriate boundary conditions that must hold
at the interface of two components (Hong et al., 2009; Sotiropoulos and
Borazjani, 2009; Vierendeels et al., 2008). As the name implies, moving
boundary methods elude to techniques that incorporate the movement of a solid
component with the movement of the fluid in evaluating the fluid and in some
cases, the solid stresses as well, as a function of the motion of the solid. In
particular, FSI techniques comprise of scenarios where the movement of the
solid-liquid interface is unknown in advance and must be determined as part of
the solution. However to date, the ability to solve FSI problems accurately is
limited largely to idealized cases, is not straight forward and is computationally
expensive. As FSI techniques in heart valve research are generally timeconsuming, during the study planning stage, their usage has to be weighed
against the added amount of accuracy that will be provided and level of
additional insights that can be gained to benefit the clinical problem at hand.
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Initial algorithmic methods included the Eulerian and Lagrangian
approach. In the Eularian case, the velocity field is provided for a fixed control
volume. The generated grid is fixed and therefore has a grid velocity, V g = 0 . It
is suitable for scenarios with small displacement and conversely is not suitable
for systems with massive boundary movement such as those that occur in valve
leaflets (Kukreja et al., 2008; Oshima et al., 2001; Sacks et al., 2009b).
In the Lagrangian method The generated grid can move and therefore has a grid
velocity equal to the velocity of the fluid, V

g

= V

f

. It is suitable when the

system can be easily identified (e.g. elastic solid) (Nguyen and Lim, 2007), but it
is not appropriate for systems with randomized boundary movement as it cannot
treat arbitrary motion which can occur for example in heart valve disease states
(e.g. severe mitral valve prolapse) (Oshima et al., 2001; Sacks et al., 2009b).
Two moving boundary algorithms used for modeling of flow in deforming
heart valves include the arbitrary Lagrangian-Eulerian (ALE) formulation and the
immersed body method (IBM). The ALE formulation can be used to solve
problems by incorporating the velocity of the mesh or grid Vg and coupling it to
the velocity of the fluid Vf. Although the ALE approach has been extensively
used, it presents the disadvantage that the mesh needs to be continuously
deformed and updated as the control volume travels through the complete
system. Given this fact, using the ALE approach could result in a large
computational expense, especially for 3D FSI problems. The ALE method is
most suitable when the definition of a fixed control volume is not sufficient, e.g.

18

when dealing with large- displacement moving walls and in some cases, when
the grid velocity can be accurately prescribed a priori (e.g. from patient specific
medical images) (Sotiropoulos and Borazjani, 2009).
On the other hand, the IBM allows for accurate interpolations at the fluidstructure interface. This method is efficient as it requires lesser to no mesh
update. It is flexible and it can be extended to multi-phase flows which makes it
suitable for various applications (Kim and Choi, 2006; Zhang and Gay, 2007).
Here, the entire fluid computational domain is discretized as an independent
mesh. Similarly, the solid computational domain is also discretized as an
independent mesh that is immersed inside the fluid domain. Although both
domains are independently meshed, their governing equations are coupled by
adding body forces to the Navier-Stokes equations that describe the fluid domain
(Gilmanov and Sotiropoulos, 2005; Kim and Choi, 2006; lmanov and
Sotiropoulos, 2005; Tai et al., 2007; Zhang and Gay, 2007). This creates a noslip boundary effect at the boundary between the fluid and the solid, and the
system accounts for these body forces at the start of the simulation until all
iterations have been run. In view of the fact that the grid used to discretize the
fluid domain is independent and does not have to be deformed or updated, the
IBM is mostly appropriate for moving boundary problems where the mesh
displacements are not known beforehand, but rather has to be resolved during
the simulation.
Hong et al. (Hong et al., 2009) developed a FSI model using the
FLUENT commercial CFD package to create a moving-grid with re-meshing
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techniques based on the ALE approach. They wanted to observe the physical
interactions of mechanical heart valves to investigate flows interacting with the
moving leaflets. Different rotating positions and tilting angles of the bi-leaflet
valves were considered. It was shown that the valve rotation had a significant
effect on the transvalvular pressure drop and that valve tilting greatly affects the
flow direction.
Ge and Sotiropolus (Ge et al., 2003) were the first to successfully use
direct numerical simulations of pulsatile flow through bileaftet mechanical heart
valves (BHMV). They simulated blood flow through a BHMV embedded within a
straight aortic segment using an IBM approach, and they conducted in vitro
studies using a similar experimental set-up. Specifically, they discretized the
computational fluid domain with a curvilinear mesh, and the immersed bodies
inside the mesh were treated as sharp-interface boundaries which were
subsequently discretized using an unstructured meshing scheme. The IBMbased model was able to closely match flow data from in vitro laboratory tests.
Sotiropolus, et al. (Sotiropoulos and Borazjani, 2009) also used the IBM to
perform high-resolution FSI simulations of a physiologic pulsatile flow through a
bi-leaflet mechanical heart valve (BMHV) in an anatomically realistic aorta and
through an identical BMHV implanted in a straight aorta. The 3D aortic
geometries were re-constructed from stacks of magnetic resonance imaging
(MRI) 2D images. The comparisons showed that although some of the salient
features of the flow remained the same, the specific geometry of the aorta (e.g.
from patient to patient) could have a major effect on both the flow patterns and
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the motion of the valve leaflets. It was also shown that higher leaflet shear
stresses were observed in the anatomical-like aorta rather than in the straight
idealized case.
When the valve material is flexible, there is higher complexity in CFD
simulations and therefore it becomes more challenging because the deformation
is localized and motions of the leaflets are highly spatially varying. This is the
case in the computational modeling of polymer tissue engineered valves. In
1972, Peskin et al. (Peskin, 1972) developed the first successful 2-D model of a
simplified mechanical heart valve inside an artery in order to capture the
movement of two solid leaflets embedded in a fluid domain. This was achieved
by using an IBM approach. Peskin et al. continued to work on improving this
method based on a finite difference scheme and later demonstrated its suitability
in capturing interactions between deforming bodies in fluids (Peskin, 1972;
Peskin and McQueen, 1980).
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Method
Eulerian

Advantages
•

Disadvantages

Good for fixed system

•

Function of space only

analysis with low/none

•

Bad for large

boundary movement
•

Computationally

deformations
•

feasible
Lagrangian

•

refinement

Neglects convective

•

Function of time only

terms

•

Bad for large

•

Easy to solve

•

Computationally

deformations
•

feasible
•

ALE

•

No adaptive mesh
refinement

Adaptive mesh( f(x) or

•

f(t) )
•

No adaptive mesh

Frequent Mesh
conformation

Good for FSI with low

•

Takes long time

boundary movement

•

Expensive for large 3D

adaptive mesh

systems

refinement if needed

•

Computationally
challenging

Immersed

•

Versatile

•

Body

•

Adequate for large
structural displacement

•

adaptive mesh

Requires deep
understanding of CFD

•

Computationally
challenging

refinement
Table 1: Summary of the advantages and disadvantages of different CFD
methodologies for moving boundary problems.
3.3 Computer Simulations of mass transport
In order for proper functioning and survival of cells and tissue, there must
be an abundant supply of oxygen and nutrients. To our knowledge, there are no
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studies conducted on the mass transport environments in TEHV constructs.
However, extensive mass transport studies have been performed in other
cardiovascular tissues such as arteries. Therefore, we have investigated the
different mass transport models used in arteries with the aim of finding a robust
mass transport model that can be used to study mass transport phenomena
happening around TEHV constructs. Arteries and other cardiovascular
structures such as heart valves obtain oxygen and glucose by mass transfer
between the tissue wall and flowing blood. Mass transfer occurs via by
convective mass transport and diffusive processes (Stangeby and Ethier, 2002;
Yang and Vafai, 2006). The first is associated with pressure-driven transmural
flow while the latter is initiated by species-specific concentration gradients (Ai
and Vafai, 2006; Ethier and Moore, 1997). These gradients are caused by
metabolic uptake and production of proteins by the cells embedded within
tissues.
Mass transport through the arteries has been studied using various
experimental, analytical, and computational methods. Extensive experimental
investigations related to the mass transfer through the arterial wall have been
pursued (Chung and Vafai, 2013; de Monte et al., 2013; Denny and Walsh, ;
Prosi et al., 2005; Yang and Vafai, 2006; Yang and Vafai, 2008). Prosi et al.
(Prosi et al., 2005) have classified these models as three major types, i.e. wallfree, homogenous-wall, and multi-layer-wall models. The simplest models are
named wall-free models. This model solves for the blood flow in the lumen while
accounting for the effects of the arterial wall simply by means of an appropriate
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set of boundary conditions. As such, the solution is independent of the mass
transport processes inside the arterial wall. The values of boundary conditions,
for instance the filtration velocity, are usually taken directly from the literature.
Because of their simplicity, the wall-free models need a relatively small number
of parameters, i.e. the diffusivity in plasma, the overall mass transfer coefficient
of the wall with respect to the considered solute and the filtration velocity.
Nonetheless, they cannot provide any information on the concentration profiles
within the wall. This model has been used for the study of the dynamics of
different solutes such as oxygen, albumin, and low-density lipoprotein (LDL)
(Lantz and Karlsson, 2012; Yang and Vafai, 2006; Yang and Vafai, 2008).
The Second type of the mass transfer models are the homogeneous- wall
models. In these models, the arterial wall is present; however, its complex
heterogeneous structure is approximated by a simple homogeneous layer. The
properties of wall are usually approximate values based on the assumption that
the arterial wall is a homogeneous porous medium. Such models represent a
reasonable compromise between the complexity of the input data and the
accuracy of the results and are functional in cases where the concentration
distribution across the arterial wall is not of primary importance. In addition to the
study of hemodynamics and its localizing role, the homogenous-wall model can
be used as a tool to investigate the interaction between the hemodynamical
parameters and the arterial wall, for instance shear-dependent permeability of
the endothelium. Homogeneous-wall models have been used by Ethier and
Moore (Ethier and Moore, 1997) to study the concentration of oxygen and LDL
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within the arterial walls. Stangeby and Ethier (Stangeby and Ethier, 2002)
modeled the fluid flow within both the lumen and wall of a constricted and
axisymmetrically stenosed artery and utilized the resulting flow pattern to study
LDL transport from blood to the arterial wall. They coupled luminal blood flow and
transmural fluid flow through the solution of Brinkman’s model. They prescribed a
constant pressure at the adventitial vasa vasorum. In addition, they allowed
variations in wall permeability due to the occurrence of plaque.
To date, the most comprehensive model used to characterize the arterial
wall is the multi-layer model (Ai and Vafai, 2006; Karner and Perktold, 2000).
This model represents the arterial wall to be composed of several heterogeneous
porous layers, i.e. endothelium, intima, and media. The multi-layer model is
advantageous over the homogeneous-wall model in that it accounts for the
particular characteristics and properties of each porous layer. However, it
requires a large number of parameters to characterize the transport properties of
each layer.
3.3.1 Overview of governing equations in CFD
3.3.1.1 Vector Operators
Using a Cartesian coordinate system with i, j, and k unit vectors ∇ can be defined
as,

=

,

,

Eq. 1

Gradient
This can be used to define the gradient of a scalar function φ (x,y,z) which results
in:
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+

Eq. 2

The gradient is a generalized derivative that acts over multiple variables of a
function.
Divergence
For a vector function U (x,y,z) where,
=

Eq. 3

The divergence of U can then be defined as:
∙

=

+

+

Eq. 4

The divergence of a vector field describes the flux at a point and therefore allows
an inference of source or sink characteristic of the field.
Dyadic Operator
The dyadic operator (tensor product) of two vectors, U and V, is defined as:
⊗

=

Eq. 5

Using specific tensor notation the vectors can be combined into a single equation
which shows as:
(
∙(

⊗ )=
(
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+

(

)

+

+

(

) Eq. 6
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+
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)
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This allows the equations in each dimension to be written into a single equation.
The tensor product is an expression of two vectors over a field that is analogous
to the product of two scalar values.
Matrix Transposition
The operator T is used to denote the transpose of a matrix. So if a matrix defined
as:

=

Eq. 7

Then the transposed matrix is:
=

Eq. 8

The Identity Matrix
The identity matrix (also called the Kronecker Delta function) is defined by:
=

Eq. 9

3.3.1.2 Governing Equations
Transport Equations
The instantaneous equations of mass, momentum, and energy conservation will
be discussed. For turbulent flows an average of the instantaneous equations is
used.
The Continuity Equation (Mass)
The continuity equation is stated as:
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∙(

+

)=

Eq. 10

is the fluid density, t is time, and U is the fluid velocity vector. The equation
states that the amount of mass entering a system is equal to the amount of mass
leaving the system.
The Momentum Equations
The momentum equation is defined as,
(

)

+

∙(

⊗ )=−

+

∙ +

Eq. 11

Where the stress tensor τ is related to the strain rate as follows:
= (

+(

) −

∙ )

Eq. 12

U represents the fluid velocity vector,

is the fluid density, p is the pressure, τ is

the stress tensor and SM is the sum of other forces moving through the system.
This equation is referred to as the Navier-Stokes equation and is used to
describe the velocity of a fluid at a given space and time. It relates the movement
of fluid across a system on the left side of the equation with the pressure,
viscous, and other forces acting on that system on the left side of the equation.
The Total Energy Equation
The total energy equation is defined as:
(

)

−

+

∙(

)=

∙(

)+

∙( ∙ )+

∙

+

Eq. 13

htot is the total enthalpy which can be related to the static enthalpy h(T,p) by,
=

+

Eq. 14
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This form of the equation is written in terms of enthalpy. However there are many
other forms that it can be take. Generally,∇ ∙ (U ∙ τ) the work due to viscous stress
is negligible because internal heating by the viscosity of the fluid is negligible.
The term U ∙ S is also neglected this is done to conserve momentum. Thus
removing the neglected terms it can be rewritten as:
(

)

−

+

∙(

)=

∙(

)+

Eq. 15

The left side of the equation represents the work done by the movement of fluid.
On the right side the first term represents energy change as a function of
temperature T and the second term is a source that represents other potential
sources of energy. The second term potentially could be zero.
The Thermal Energy Equation
The thermal energy equation is an alternative form of the total energy equation
that can be used with low-speed flows. To begin mechanical energy K is defined
as,
=

Eq. 16

Taking the dot product of this equation with the momentum equation yields:
(

)

+

∙(

)=− ∙

+

∙( ∙ )+

∙

Eq. 17

Which when subtracted from the total energy equation yields the thermal energy
equation:
(

)

−

+

∙(
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∙(

)+

∙

+ :

+

Eq. 18

Two different assumptions based on the fluid can be used to simplify the
equation to the following final form:
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(

)

+

∙(
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∙(

)+ :

+

Eq. 19

If the fluid in question is a liquid in which variable-density effects are negligible
then h can be interpreted as internal energy,
e=h−

P
ρ

This allows the previous equation to be rewritten as
(

)

+

∙(

)=

∙(

)−

∙

+ :

+

Eq. 20

Which is equivalent to the final form when e is interpreted as h and −p∇ ∙ U is
neglected
If the fluid is a compressible gas with low Mach flow then

and U ∙ ∇p are

neglected leading to the same final form. The thermal energy equation is useful
for avoiding stability issues in the total energy equation. It cannot be used if
proper acoustic behavior is required or in the case of high speed flow.
Equations of State
The transport equations must be augmented with constitutive equations of state
for density and enthalpy in order for the equations to form a closed system. In
general the equations take the form:
= ( , )

+

=
=

Eq. 21

( , )

=

+

Eq. 22

Eq. 23
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Incompressible Equation of State
This is the simplest case. Density is constant and cp at most a function of
temperature.
=

Eq. 24

=

+

Eq. 25

c = c (T)
Ideal Gas Equation of State
For an ideal gas, density is calculated from the ideal gas law and cp can be at a
function of temperature.
=

Eq. 26

=
=

Eq. 27
( )

Eq. 28

Real Gas and Liquid Equations of State
For real gases and liquids a slightly more complex approach is necessary when
deriving equations of state. Cubic equations of state are the most convenient
means for predicting real fluid behavior. Four versions are used in Ansys: the
Standard Redlich Kwong, Aungier Redlich Kwong, Soave Redlich Kwong, and
Peng Robinson.
Redlich Kwong Models
Redlich Kwong variants of the cubic equations of state take the form:
=

−

( )
(

)

Eq. 29
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v is the specific volume v = 1 ρ and a, b, and c are variable that vary from model
to model.
The Standard Redlich Kwong Model
In the Standard Redlich Kwong Model c is set to zero and a is set to:
=

Eq. 30

Where
n is 0.5
.

=
=

Eq. 31

.

Eq. 32

The Aungier Redlich Kwong Model
The Aungier form differs by having a non-zero value for c in order to improve the
value of isotherms near the critical point. The value of n also differs based on the
pure substance. The parameter c takes the form of:
=

+
(

−

Eq. 33

)

The exponent n is replaced with a best fit polynomial in terms of the acentric
factor ω.
= .

+ .

+ .

Eq. 34

The Soave Redlich Kwong Model
The Soave Redlich Kwong Model applies to non-polar compounds and improves
upon the original by generalizing the attraction term to depend on the acentric
factor. This accounts for the fact that molecules are non-spherical and a range of
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vapor pressure data in the development of the temperature dependency of this
parameter. b takes the same form as the original and c as well is the same. a(T)
however takes the form:
( )=

+

−

Eq. 35

Where
a0 is just a from the standard model
= .

+ .

− .

Eq. 36

Peng Robinson Model
The Peng Robinson Model takes a similar form as the Redlich Kwong Model but
differs slightly and is defined as:
=

−

( )

Eq. 37

Where
= .

( )=

Eq. 38

+

−

= .
= .

Eq. 39

Eq. 40
+ .

− .

Eq. 41

General Equations of State
Equations of state can be user defined in CFX such that they are the following
functions
= ( , )

Eq. 42
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( , )

=

Eq. 43

Noting that:
=

−

Eq. 44

In which v=1/ . Solving for enthalpy yields:
=

+

−

Eq. 45

Noting that user defined expressions must be thermodynamically consistent
requires that all the mathematical properties for exact differentials be satisfied.
Therefore dz(x,y) is an exact differential defined as:
( , )=

+

Eq. 46

With,
=

Eq. 47

=

Eq. 48

Consistency requires that:
=

Eq. 49

With this in mind, for a general equation of state to be consistent it must obey the
following:
=

−

Eq. 50

Note that it is only valid to specify a general equation of state in which density is
a function of T alone.
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Conjugate Heat Transfer
It is possible to create a solid region in which the equations for heat
transfer are solved but those for flow are not. This is known as conjugate heat
transfer and the solid region is known as a solid domain. The conservation of
energy equation can be used to describe the transfer of heat due to the motion of
the solid, conduction, and volumetric heat sources:
(

)

+

∙(

)=

∙(

)+

Eq. 51

Where h is the enthalpy, ρ is the density, λ is the thermal conductivity of the solid,
and SE is an optional volumetric heat source. US represents the solid velocity
which accounts for the motion of the solid with respect to a reference frame.
3.3.1.3 Multicomponent Flow
Scalar Transport Equation
For a multicomponent fluid the Governing equations are used to solve for the
bulk fluid however additional equations must be solved in order to determine how
each component of the fluid is transported within the bulk. Each component has
an individual conservation of mass equation and after Reynolds-averaging the
equation can be expressed in tensor notation as:
+

(

)

=−

−

−

"

"

+

Eq. 52

Where:
ρ is the mass average density of the fluid component i in the mixture
U = ∑ (ρ U )⁄ρ is the mass average velocity field
U is the mass average velocity of fluid component i
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ρ (U − U ) is the relative mass flux
Si is the source term for component i which includes the effects of chemical
reactions
If all the terms in the expanded equation are summed over all the components
then the result is simply the standard continuity equation:
+

(

)

=

Eq. 53

This is because the reaction rates Si must sum to zero.
The relative mass flux term accounts for differential motion of the individual
components. Depending on how it is modeled it can describe the effects of
concentration gradients, pressure gradients, external forces, or temperature
gradients. The primary effect of motion among the individual components is the
concentration gradient and modeling of this effect gives yields diffusion-like term
given by:
−

=−

Eq. 54
i,

The molecular diffusion coefficient,

is assumed to be equal to Di where Di is

the kinematic diffusivity. The mass fraction of component i is then defined as:
=

Eq. 55

Plugging the previous two equations in to the conservation of mass equation
yields:
(

)

+

(

)

=

−

"

"

+

Eq. 56

The turbulent scalar fluxes are modeled using the eddy dissipation assumption:
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"

−

"

=

Eq. 57

S is the turbulent Schmidt number. This can then be substituted into the
equation and assuming that you have mass weighted averages of Yi the final
equation is defined as:
(

)

+

(

)

=

+

Eq. 58

Where:
=

+

Eq. 59

Constraint Equation for Components
The CFX-solver solves NC-1 mass fraction equations for all but one component
so the last component is known as the constraint component. The last mass
fraction is determined by the equation:
∑

, , ,…

=

Eq. 60

Multicomponent Fluid Properties
If there is a given volume V of fluid mixture then Mi is the mass of component i
present in the volume; ρi =Mi/V is then the density of that component; Vi is the
partial volume of that component that would be taken up by that component of
the same mass at the same local temperature and pressure as the mixture. The
thermodynamic density of the component is an evaluation of the equation of state
under the mixture temperature and pressure is expressed as〈ρ 〉 =
all partial volumes must add up to the total volume, then:

37

M

V . Since

=∑

=∑

, ,…

〈 〉
, ,…

=∑

, ,… 〈 〉

=∑

Eq. 61

, ,… 〈 〉

Or:
=∑

, ,… 〈 〉

Eq. 62

Thus the mixtures density can be calculated with knowledge of the mass
fractions and thermodynamic density of each component.
An arbitrary constitutive property may be calculated from:
=∑

Eq. 63

, ,…

Where α can be the laminar viscosity µ, the specific heat at constant volume cv,
the specific heat at constant pressure cp, and the laminar thermal conductivity λ.
Energy Equation
Extending the conservation of energy equation to multicomponent fluids requires
adding an additional diffusion term:
∑

Eq. 64

For turbulent flows this term is Reynolds-averaged giving:
∑

"

+

+

"

"

Eq. 65

Though this expression contains several fluctuating terms it is not possible with
current models to account for these effects individually thus only the mean effect
is retained in the calculations. Inserting this extra term into the energy equation
yields the following equation:
(

)−

+

=

+∑

+
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+

Eq. 66

Multicomponent Energy Diffusion
In the special case that all diffusivities are the same and equal to thermal
conductivity divided by specific heat capacity:
=

=

Eq. 67

This holds when the Lewis number is unity for all components: Lei=λ/(cpΓi)=1 for
turbulent flow assuming unity is usually just as good just as good as the common
practice of using the unity Schmidt number. For Lei=1 the energy equation
simplifies exactly to the following:
(

)−

+

=

+

+

Eq. 68

This equation has the advantage of having only a single diffusion term reducing
the number of computations. When component dependent turbulent Schmidt
numbers are specified then turbulent energy flux must be specified. This can be
achieved by splitting turbulent fluctuation of enthalpy into its contributions from
temperature, pressure, and component mass fractions:
"

"

≈

"

+

"

+∑

Eq. 69

Using this transformation the turbulent energy flux can then be modeled using
the eddy diffusivity model with turbulent Prandtl number for the temperature
fluctuations plus the sum of the secondary enthalpy transport terms:
−
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Eq. 70
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Eq. 71
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−
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−∑
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Inserting the eddy diffusivity model for turbulent component mass fluxes yields
the following model for the turbulent enthalpy flux:
” "

−

≈

∙

+

∙
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Eq. 72

,

Using these relations with the energy equation allows it to be rewritten for
generalized turbulent component transport:
(

)−
"

"

+

=

+

+

+

∙

+∑

+

Eq. 73

If the eddy diffusivity assumption is being used to model the turbulent mass flux
for each component then the equation becomes:
(

)−

+

=

+

+

+

∙
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+

Eq. 74

,

3.3.1.4 Additional Variables
Transport Equations for Additional Variables
The general form of the transport equation for an additional variable is:
(

)

+

∙(

)=

∙

+

Eq. 75

Where:
U is the fluid velocity in a fluid or porous domain or Us in the case of solid motion
velocity with Us is the solid velocity
is the mixture density in mass per unit volume
Φ is the conserved quantity per unit volume, or the concentration
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φ=Φ/ is the conserved quantity per unit mass
Sφ is a volumetric source term, with units of conserved quantity per unit time
DΦ is the kinematic diffusivity for the scalar
For turbulent flow, this equation is Reynolds-averaged and becomes:
(

)

+
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)=

∙

+

+

Eq. 76

Where:
Sct is the turbulence Schmidt number
µt is the turbulence viscosity
Diffusive Transport Equations for Additional Variables
The general form of the diffusive transport equation for an additional variable
(non-reacting scalar) is:
(

)

=

∙

+

Eq. 77

The variables are all the same as in the regular transport equation.
Poisson Equations for Additional Variables
The general form of the Poisson equation for an additional variable (non-reacting
scalar) is:
∙

+

=

Eq. 78

The variables are also the same as the past two equations.
Momentum Sources
A momentum source is implemented as a force per unit volume acting on the
fluid(s). Momentum sources can be used to model isotropic losses in porous
regions, directional losses in porous regions among other processes.

41

Isotropic Loss Model
The momentum loss through an isotropic porous region can be formulated using
permeability and loss coefficients as follows:
,

=−

−

| |

Eq. 79

,

=−

−

| |

Eq. 80

,

=−

−

| |

Eq. 81

Where Kperm is the permeability coefficient and Kloss is the quadratic loss
coefficient. The linear component of this source represents the viscous losses
and the quadratic term represents inertial losses. Alternatively the source may be
formulated using linear and quadratic resistance coefficients substituting CR1 and
CR2 for the others as follows:
=

Eq. 82

=

Eq. 83

3.3.1.5 Directional Loss Model
The momentum source through an anisotropic porous region may be modeled
using the directional loss model. With this model the streamwise direction must
be specified. If the streamwise coordinate system was (x’,y’,z’) such that the x’axis is aligned with the streamwise direction and the y’ and z’ axes lie on the
transverse plane then the momentum losses in these directions are:
,

=−

−

| |

Eq. 84

,

=−

−
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Eq. 85
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,

=−

| |

−

Eq. 86

In this case there is an individual permeability and loss coefficient term for both
the stream-wise and transverse directions. Just as in the isotropic model these
may be expressed in terms of the linear and quadratic resistance coefficients.
3.3.1.6 General Momentum Sources
The general momentum source is available in the instance that there sources are
not covered by the isotropic or directional loss models. A source for each
direction is given by:
,

=

,

Eq. 87

,

=

,

Eq. 88

,

=

,

Eq. 89

Where Sspec are the specific momentum components. Additionally a
representative scalar linearization coefficient based on the derivate
Eq. 90
May be specified to provide robust convergence when a general momentum
source is present.
3.3.1.7 Immersed Solids
An immersed solid is a rigid compact body capable of moving within a fluid
domain. In order to capture the movement of the immersed body, the fluid
volume is forced to move with the solid by applying a source term to the
momentum equation.
=−

(

−

)
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=−

(

−

)

=−

(

−
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Where

,

,

are the three components of fluid velocity.

,

,

are the components of forcing velocity due to the immersed solid.

− is a large number, and is evaluated as the average of the three diagonal
coefficients in the momentum equation.
is the Momentum Force Scaling Factor.
3.4

CFD usage for emerging technologies in Heart Valve Research
Driessen et al. (Driessen et al., 2007) employed a mathematical model to

study the mechanical properties of a TEHV. Engelmayer et al. (Engelmayr et al.,
2008) utilized GAMBIT® (v2.1) and FLUENT ® (v6.2) ( Ansys, Canonsburg, PA)
to study flow behavior through a novel bioreactor for heart valve tissue
engineering. Computational studies on the flow physics on and around the
housed bioreactor specimens (Engelmayr et al., 2008) were subsequently
evaluated further by Ramaswamy et al. (Ramaswamy et al., 2010). The
commercially available software FLUENT ® (Ansys, Canonsburg, PA) was
employed on a structured grid composed of 1.43 million hexahedral elements
and 1.54 million nodes. They hypothesized that the oscillatory shear stresses
that were created during specimen, valve-like bending were involved in
engineered heart valve tissue formation (Ramaswamy et al., 2010).
Ramaswamy et al. (Ramaswamy et al., 2014) also developed a u-shaped novel
bioreactor. Its design permitted the in vitro recreation of physiologically relevant
shear stress magnitudes.
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Figure 3. Custom made mechanical conditioning bioreactor for HVTE studies
(Engelmayr et al., 2006). Modes: Flow, stretch, flexure.

Figure 4. Computational fluid dynamic simulations on native heart valve (a) and
rectangular (b) Geometries (Ramaswamy et al., 2010).

45

3.5 Recent Advances in CFD Applications for Heart Valve Research
3.5.1 Imaging to Meshing to CFD
Blood flow physics that occur in the neighborhood of native or prosthetic
valves can be a key indicator of the functionality of the valve (Sotiropoulos and
Borazjani, 2009). It can reveal disease in native valves (Ryan et al., 2006;
Schlosshan et al., 2011) and performance issues in the case of prosthetic ones
(Sotiropoulos and Borazjani, 2009). In order to develop a strong-accurate CFD
model, the incorporation of these flow physics as boundary or initial conditions is
paramount (Le and Sotiropoulos, 2013; Wong et al., 2012). Equally important is
the usage of geometry structures that correctly depict valve and surrounding
tissues in vivo (Le and Sotiropoulos, 2013). This represents a key challenge due
to the light scattering nature of blood which excludes the usage of some imaging
techniques (Sengupta et al., 2012a). It is also important to be able to compare
computational results with experimental data, and this can be achieved only if the
valvular flow physics can be sufficiently captured in vivo.
Doppler echocardiography and cardiac magnetic resonance (CMR) have
typically been used to obtain mainly unidirectional velocity profiles (2D)
(Cavalcante et al., 2012; Sengupta et al., 2012a). More advanced versions such
as the 4D flow CMR can provide temporal and 3D spatial information (Sengupta
et al., 2012a) with resolution in the order of 50ms and 3mm3, respectively
(Sengupta et al., 2012a). Color Doppler echocardiography has been used to
observe abnormal flow patterns and superimposed turbulence (Ryan et al., 2006;
Schlosshan et al., 2011). It does so via application of an ultrasonic beam that can

46

be used to compute axial velocities (Leopaldi et al., 2012; Ryan et al., 2006). It
can also provide radial velocities, but the integration of both radial and axial
velocities, necessary for obtaining the true flow field, is not usually obtained in
routine clinical management (Sengupta et al., 2012a).
Particle image velocimetry (PIV) is a popular technique for the
characterization of the flow field through heart valves and chambers (Sengupta et
al., 2012b). It is capable of capturing a highly physiologically similar flow field by
using tiny particles that light up in response to the presence of a laser light. PIV
does not track the individual particle displacement; it tracks the alignments of the
particles as a group (Lim et al., 1998). Imaging technologies such as computer
tomography (CT) scans, ultrasound and MRI can help in the virtual geometry
reconstruction of cardiovascular component such as heart valves, chambers, and
vessels (De Bartolo et al., 2012; Lantz and Karlsson, 2012; Le and Sotiropoulos,
2013; Wong et al., 2012). For instance, CT consists of taking multiple 2D cross
section images that can be later stacked together for 3D reconstruction
(Sengupta et al., 2012b). Presently, the accuracy and acceptability of CFD
models greatly rely on these types of imaging techniques, which are capable of
acquiring extensive 2D data that can be later processed to reconstruct 3D
structures (Le and Sotiropoulos, 2013).
The advancement in imaging technologies, computational capabilities,
better understanding of electrophysiology of the heart and its interactions with
neighboring tissues and organs have infused new hope for the development of a
virtual model that can closely resemble that of the heart and its valves
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(Cavalcante et al., 2012; De Bartolo et al., 2012; Le and Sotiropoulos, 2013).
Meshing geometries with high density elements and nodes can be promptly
accomplished through super computers (Haj-Ali et al., 2008; Kleinstreuer, 2006;
Salinas et al., 2014a; Salinas et al., 2014b). Geometry re-meshing can be
triggered by setting tolerance levels for specific parameters such as element
volume or element angle deformation thereby delaying negative volume sectors
which will cause computational errors that will terminate the iteration process
without yielding any results (Ansys, 2014). Parallel processing with state of the
art processors makes the iterative solution process more efficient. It is a common
practice to set the number of iterations in the thousands. It also helps to achieve
academic and research standard convergence criteria for continuity and
momentum equations (Ramaswamy et al., 2010; Salinas et al., 2014a; Salinas et
al., 2014b). We outline a few of the most up-to-date efforts in heart valve
computational fluid modeling that were able to leverage accurate geometric
reconstructions derived from original medical imaging datasets. We include
specific case studies where appropriate (labeled with a case number) when
visual illustrations are also provided. Case # 1: Le and Sotiropoulos (Le and
Sotiropoulos, 2013) employed the curvilinear immersed boundary method and
developed a FSI model of a left ventricle and a mechanical heart valve. The 3D
reconstruction of the ventricle geometry was obtained by merging 2D MRI
images from a healthy individual. The results were found to be in good
agreement with clinical observations. This work revealed complex valve leaflet
kinematics and emphasized the importance of patient specific simulations for
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heart valve prosthesis and other cardiac devices. In Figure 5, it can be seen that
there was the formation of coherent structures at different time points during the
cardiac cycle. Coherent structures were well developed zones within the flow that
exhibited a characteristic flow pattern such as vortices. Studying the formation
and transient life of such structures could help in understanding damage to blood
cells as well as prosthetic valve dynamics.

Figure 5. The formation of coherent structures inside the left ventricular chamber
during diastole in (a). The small scale structures are advected into the aorta
during systole in (d). The red dot in the inset shows the time instance in the
cardiac cycle. (From Le TB, Sotiropoulos F. Fluid-structure interaction of an
aortic heart valve prosthesis driven by an animated anatomic left ventricle. J
Comput Phys. 2013(244):41-62. With permission from Elsevier)
Pellicioni et al. (Pelliccioni et al., 2007) utilized the Lattice-Boltzman (LB)
method in a flow simulation past a mechanical valve in the aortic position. Other
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efforts that have utilized the same approach include the work of Krafczyk et al.
(Krafczyk et al., 1998; Krafczyk et al., 2001). These efforts showed that the LB
method was capable of predicting blood flow physics accurately.
Case # 2: Shahriari et al. (Shahriari et al., 2012) developed a model for a
bi-leaflet mechanical valve flow study. The model employed a smoothed particle
hydrodynamics approach which is a mesh free approach. This study was the first
of its kind to use this technique in the area of heart valve research and was
originally developed for the astrophysics arena. Essentially, the fluid is
represented by interacting particles that obey the Navier-Stokes equation using
an interpolation function. The particles can move freely in the reference frame
with a Lagragian configuration. The trajectory of the particles was used to
correlate flow patterns with damage to blood components. In addition, large
recirculation regions were found to be present in the dysfunctional BMHVs as
shown in Figure 6.
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Figure 6. The patterns associated with accumulative shear stress applied on
particles passing through: (a) a normal BMHV and (b) a dysfunctional
BMHV.(From Shahriari S, Maleki H, Hassan I, Kadem L. Evaluation of shear
stress accumulation on blood components in normal and dysfunctional bileaflet
mechanical heart valves using smoothed particle hydrodynamics. J Biomech.
2012;45(15):2637-2644. With permission from Elsevier)
Case # 3: Borazjani(Borazjani, 2013) developed a three-dimensional FSI
model for both mechanical and bio-prosthetic valves. He used a Fung model for
the soft tissue and validated his results with experimental and numerical heart
valve tissue data. The mechanical results were validated using flow
measurements from a mechanical heart valve. Figure 7, 8 and 9 show the
comparison of shear stress, structure formation and the non-dimensional second
Piola–Kirchhoff stress. It can be seen that shear stress acting on blood
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components was higher in the mechanical valve. Other efforts have shown a
correlation between higher shear stress and thrombus nucleation(Banerjee,
2013; De Bartolo et al., 2012). The non-dimensional second Piola-Kirchhoff
stress was used to identify the points of maximum stress which found to occur
when flow pushed the valve toward the open position.

Figure 7. FSI simulations with peak Re = 6000: Comparison of instantaneous
local maximum shear sloc contours over the midplane of the valve for an MHV
vs. BHV implanted in a straight aorta at time t = (a) 52, (b) 93 , (c) 186, and (d)
334 ms within the cardiac cycle. (From Borazjani I. Fluid–structure interaction,
immersed boundary-finite element method simulations of bio-prosthetic heart
valves. Comput Methods Appl Mech Eng. 2013;257(0):103-116. With permission
from Elsevier)
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Figure 8. FSI simulations with peak Re = 6000: 3D wake structure visualized by
the iso-surfaces of q-criteria for a MHV vs. BHV implanted in a straight aorta at
time t = (a) 52, (b) 93 , (c) 186, and (d) 334 ms within the cardiac cycle. (From
Borazjani I. Fluid–structure interaction, immersed boundary-finite element
method simulations of bio-prosthetic heart valves. Comput Methods Appl Mech
Eng. 2013;257(0):103-116. With permission from Elsevier)
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Figure 9. FSI simulations of BHV: The shape of the BHV and the magnitude of
the non-dimensional second Piola–Kirchhoff stress S on the BHV at time instants
t = (a) 52, (b) 93 , (c) 186, and (d) 334 ms within the cardiac cycle. (From
Borazjani I. Fluid–structure interaction, immersed boundary-finite element
method simulations of bio-prosthetic heart valves. Comput Methods Appl Mech
Eng. 2013;257(0):103-116. With permission from Elsevier)
Case # 4: We performed computational simulations of flow in a custom
made bioreactor (Ramaswamy et al., 2014) capable of imparting physiologically
relevant shear stresses onto rectangular scaffolds (Figure 10). The rationale for
replicating native valve flow physics on rectangular surfaces was previously
documented (Ramaswamy et al., 2010).
The movement of the samples was assumed to follow a parabolic profile
during cyclic flexure deformation (Salinas et al., 2014a; Salinas et al., 2014b). In
this study we wanted to observe the effect of flow pulsatility versus sample
movement on oscillatory shear stresses (OSS). OSS has been shown to be

54

important in the differentiation pathways of bone marrow derived stem cells
(BMSCs) (Arnsdorf et al., 2009b; Arnsdorf et al., 2009a; Jacobs et al., 1998).
Our interests were in BMSC differentiation to support the heart valve phenotype,
as it is a popular cell choice utilized in heart valve tissue engineering studies.
We performed a quasi-static analysis on steady flow simulations at different
sample bending positions. Pulsatile simulations were performed for fixed sample
positions as described in Salinas et al.(Salinas et al., 2014a; Salinas et al.,
2014b). All the simulations were carried out using CFX ® (Ansys, Canonsburg,
PA) software with parameters described in Figure 11.

Figure 10. (A) Peristaltic pump used to induce flow through the FSF bioreactor.
(B) FSF bioreactor set up. (C) Single FSF bioreactor chamber. (D) Bioreactor
fluid domain showing the position of the three rectangular specimens.
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Figure 11: (a) U-shaped bioreactor showing the three samples. (b) Front view of
the bioreactor inlet, outlet and sample position. The Table indicates the
parameters for steady and pulsatile simulations.
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Figure 12: OSI distribution along the centerline of samples for (a): Inner wall and
(b) Outer wall.Notice how the OSI variability was lowest along the inner and outer
walls of straight samples (N=3) subjected to pulsatile flow. The average OSI in
the inner surface was found to be 0.2627, 0.2121, 0.2396, and 0.1009 for
straight, semi-bent, fully-bent, and quasi-static, respectively. In that same order,
the outer wall values were 0.2689, 0.1859, 0.2159 and 0.2485 (Salinas et al.,
2014a; Salinas et al., 2014b).
An oscillatory shear index (He and Ku, 1996) was used to quantify the
OSS along the center line of the specimens. OSI was overall found to be the
most uniform along both walls (inner and outer) for straight specimens that
underwent pulsatile flow (Figure 12). In addition, mean OSI distribution was
highest along both the inner and outer walls when specimens (N=3) were held
fixed in a straight configuration (average specimen OSI = 0.26, inner wall;
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average specimen OSI = 0.27, outer wall). Thus, these types of analyses
illustrate an example of deriving insights from computational efforts without
building complex CFD models (e.g. FSI), in aiding the design of experiments. In
this case, the models guided the planning of maximizing OSS levels in BMSCseeded scaffolds uniformly. Subsequent evaluation of OSS-induced
mechanobiology, could thus be accomplished in a clear-cut fashion, purely
through a physiological pulsatile waveform, without the need for moving the
specimens (Salinas et al., 2014a; Salinas et al., 2014b).
3.6 Conclusions and Future Outlook
The advent of new technologies such as tissue engineered heart valves
and percutaneously-deployed valves are areas that are still relatively
understudied using CFD. In this regard, several insights may be gained even
from very straightforward modeling approaches (e.g. laminar flow, static models)
provided that accurate depiction of the geometric features can be reproduced.
On the other hand, the culmination of CFD research over the last several years
has enabled streamlining of more advanced methodologies such as FSI-based
approaches, to the extent that research groups that utilize their in-house
developed code are able to simulate very complex dynamic states of heart valves
in a highly efficient fashion. While these approaches are also available in
commercial CFD packages, direct control of localized deformation states is still
tedious. In the years to come, it is expected that these packages will begin to
offer more flexibility in the prescription of mesh movement, thereby allowing for
more direct control of the simulations by the end-user.
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Irrespective of whether the usage of an advanced CFD techniques
become commonplace, or if several insights on the flow physics can be
uncovered in emerging heart valve therapeutics using CFD, we expect that the
findings resulting from CFD simulations in the heart valve research area will now,
perhaps more than ever before, play a central role in the research or clinical
process. This can be by way of, for example, enhancing the design features of a
tissue engineered heart valve or a prosthetic valve, or alternatively, towards the
evaluation of in vivo valve functionality, thereby guiding the surgeon in selecting
the next course of treatment for the patient.

CHAPTER 4: COMPUTER SIMULATIONS OF VALVE LIKE DEFORMATIONS
4.1 Introduction
Tissue engineered heart valves (TEHVs) could potentially serve as a
viable solution to congenital valve disease among pediatric patients who
currently have extremely limited options (Fong et al., 2006; Kadner et al., 2002;
Martinez et al., 2013; Schmidt et al., 2006). The primary appeal of TEHVs lies in
their potential to integrate and grow with the patient, but in addition, TEHVs could
potentially overcome current valve replacement barriers such as hemolysis,
immune rejection, calcification, anticoagulation therapies and the need for
multiple invasive surgeries (Chen et al., 2013; Hmiel, 2012; Leong et al., 2013;
Munnelly et al., 2012; Nora et al., 2012; Syedain, 2009a).
As with native heart valves, the mechanical environment that TEHVs are
exposed to will direct the nature of tissue remodeling that will occur. Studies have
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examined the remodeling responses of TEHVs using a variety of cell sources,
both in vivo as well as in vitro in heart valve bioreactors, i.e., devices that impart
valve-relevant mechanical stimuli (some combination of cyclic flexure, flow and
cyclic stretch) to developing tissues. Many bioreactor-based studies have
associated higher cell activity and tissue formation with fluid induced shear
stresses (Kadner et al., 2002; Karim et al., 2006). A landmark study conducted
by Engelmayr et al. (Engelmayr et al., 2006) utilized a bioreactor to condition
rectangular polyglycolic acid /poly L-lactic acid (PGA/PLLA) non-woven fibrous
scaffolds seeded with bone marrow stem cells (BMSCs). They reported that the
combination of cyclic flexure and steady flow (flex-flow) greatly augmented
engineered collagen formation when compared to steady flow or cyclic flexurealone. Interestingly, studies elsewhere described that oscillatory flow conditions
mechanically regulate BMSCs (Arnsdorf et al., 2009b; Arnsdorf et al., 2009a; Li
et al., 2004; Vermot et al., 2009). Indeed, oscillatory shear stress (OSS) has
been shown to mediate BMSC proliferation and differentiation, (Arnsdorf et al.,
2009b; Arnsdorf et al., 2009a). Specifically, Arnsdorf et al. (Arnsdorf et al.,
2009b; Arnsdorf et al., 2009a) reported that OSS has the potential to promote
osteogenic differentiation of BMSCs by activating key molecular pathways;
meanwhile, Li et al. (Li et al., 2004) reported an increase in BMSC proliferation in
addition to increases in intracellular Ca2+ signaling. Particularly relevant to heart
valves, OSS was also found to directly regulate the gene klf2a which is required
for normal valve development (Vermot et al., 2009).
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As a mechanical conditioning metric, steady flow on its own will serve to
impart shear stresses, while cyclic flexure-alone will impart OSS on the surfaces
of engineered tissue. It is only in flex-flow states that both shear stress
magnitude and OSS will be augmented. Thus in the current study, our primary
objective was to computationally quantify specimen surface: (1) shear stress
magnitudes and (2) OSS present under, i) No flow, no flexure (control group) ii)
steady flow-alone, iii) cyclic flexure-alone and iv) flex-flow states, and to
subsequently co-relate them to previous experimental studies on engineered
collagen production (Engelmayr et al., 2006) under these four corresponding
culturing environments.
4.2 Methods
4.2.1 Overview
Computational Fluid dynamic (CFD) simulations of a flow-stretch-flexure
(FSF) bioreactor available in our laboratory were performed. The physical
description of the FSF bioreactor has been provided in detail previously
(Boronyak et al., 2009; Ramaswamy et al., 2009a; Ramaswamy et al., 2013;
Ramaswamy et al., 2008). The FSF bioreactor modeled in the present study is
distinct from, but based on, the first FSF bioreactor, originally developed and
reported by Engelmayr et al. (Engelmayr et al., 2008; Engelmayr et al., 2006).
Briefly, the new device (Figure 13) can induce FSF stresses at the physiological
range for up to three rectangular scaffolds per conditioning chamber without
using viscosity additives. The complete set up comprises of four chambers. The
sample movement is generated by an external actuator, and the flow is induced
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through a peristaltic pump. As mentioned, the individual and combined effects of
steady flow and sample cyclic flexure on the regional flow physics of rectangular
scaffolds were simulated in four cases.
Actuator
a)
Media
Source
Pump

Direction of linear motion
Moving posts
b)
Outlet
Inlet

Fixed posts

Figure 13: a) Shows a single bioreactor chamber connected to media source.
The media is pumped into the bioreactor by a peristaltic pump (Boronyak et al.,
2009; Ramaswamy et al., 2009a; Ramaswamy et al., 2009b; Ramaswamy et al.,
2010; Ramaswamy et al., 2011; Ramaswamy et al., 2014). An external actuator
attached to one end of the samples provides movement. b) Shows an inside look
of the bioreactor. The chamber can hold three specimens. Each sample has one
end fixed while the other is allowed to move linearly by means of the actuator.
4.2.2 Mesh Construction, Simulation Set-up
A 3D virtual geometry of the bioreactor’s fluid domain was created (Design
Modeler, Ansys Inc., Canonsburg, PA). The domain sample dimensions were 17
X 6.5 X 1 (mm). A quadrilateral-element, structured mesh was subsequently
constructed (Ansys Meshing, Ansys Inc., Canonsburg, PA). Since we were
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looking at the flow patterns-alone, the samples were suppressed after meshing
and only the mesh for the fluid domain was imported into the CFD software for
simulations (CFX 14.5 version, Ansys Inc, Canonsburg, PA). All simulations
performed in this study imposed a Newtonian, viscous model, with laminar flow
conditions and the following material parameters: the physical properties for
bioreactor media were used with density = 1.01g/cm3 and dynamic Viscosity =
1.27 cp. A zero relative-pressure condition was also applied at the outlet. Finally,
a no slip boundary condition was prescribed to the bioreactor walls and also to
the samples, for the cases where they did not move (no flow, no flexure and
steady flow-alone). In all the CFD simulation runs, the models were analyzed
once a convergence criteria of 1x10-9 for the momentum and continuity equations
were achieved. Simulations were conducted in a Hewlett Packard work station
with intel(R) Xeon(R) CPU, x5550@ 2.67GHz (2 processors) with 16.0 GB
installed memory and 64-bit windows 7 operating system.
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a)

b)
t =0 sec

t =0.5 sec

c)

d)

t =0.75 sec t =1 sec
t =0 sec
t =0.25 sec t =0.5 sec
Figure 14: a) Depicts the entire fluid domain of the bioreactor chamber. Note the
three scaffolds in a straight configuration and the plane (in red) at x = 0.075m
corresponding to the longitudinal center line of the samples. b) Cross section (x
=0.0175m) of the structured mesh (which consisted of 441,370 elements and
472,728 nodes) showing the distribution of quadrilateral elements and nodes.
Note that the element density is higher around the samples and lower as it
approaches the outlet. c) A close-up of the mesh around a single sample. The
elements around the vicinity of the samples were aligned to conform to the
flexing shape of the specimens. d) Close-up of the sample edge during t = 0s, t
=0.25 s, t =0.5 s, t = 0.75 s, t = 1 s.
4.2.3 Mesh Independence
A similar simulation of the steady flow-alone case has been described in
previous efforts (Salinas et al., 2014a; Salinas et al., 2014b). In that investigation,
a relatively fine tetrahedral mesh consisting of 3.1x106 elements and 5.5x105
nodes was employed. The results revealed that the sample area-averaged shear
stress was 0.031 Pa. We continued optimizing our structured mesh density until
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a mesh consisting of 441,370 quadrilateral elements and 472,728 nodes (Figure
14) computed a corresponding average shear stress value that was found to be
within 2% variability. This mesh was subsequently employed for all succeeding
CFD simulations.
4.2.4 Simulations involving non-moving samples (no flow, no flexure and
steady flow-alone)
In the control group, the samples were non-moving and an inlet flow
velocity of negligible quantity was prescribed (1x10-7m/s). For the steady flow
case, the samples were still held stationary and an inlet plug velocity profile of
0.022 m/s was prescribed. Peak flow velocities in previous FSF bioreactor
studies (Engelmayr et al., 2008) were determined to be in the order of 0.08 m/s.
In the current computational study, we chose to prescribe an inlet velocity of
0.022 m/s which represents a time-averaged blood velocity in the pulmonary
artery (Lotz et al., 2002) and therefore is of particular physiological relevance to
tissue engineered pulmonary valves. This prescribed velocity can readily be
faciltiated by the flow source (Boronyak et al., 2009; Ramaswamy et al., 2009a;
Ramaswamy et al., 2009b; Ramaswamy et al., 2010; Ramaswamy et al., 2011;
Ramaswamy et al., 2014) of the FSF bioreactor modeled in this study. Three
fixed specimen configurations were simulated in the steady flow-alone case: fully
straight, semi-bent, and fully bent. These snapshot configurations corresponded
to the initial, mid and final specimen shapes during the bending event.
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4.2.5 Simulations involving moving samples (cyclic flexure-alone and flexflow)
In the CFD simulations for cyclic flexure-alone, the samples were allowed
to bend, but the inlet velocity was set to zero. In the flex-flow simulation, the
samples were flexed and the inlet plug velocity profile was set to 0.022 m/s. The
set up and simulation of the flex-flow case is described in detail in (Ramaswamy
et al., 2014). In brief, the samples were assumed to bend as a parabola. The
construct deformed from a straight to bent configuration in 0.5 s, and then from a
fully bent to straight state in the next 0.5 s. At a time step of 2 ms, the samples
were re-meshed to represent the change in sample shape while its movement
was incorporated using an Arbitrary Lagrange Eularian (ALE) approach.
Specifically, the ALE formulation uses a grid velocity which is coupled to the flow
equations via the space conservation law. Details concerning the ALE
formulation has been reported previously (Ansys, 2014; Lai and Przekwas, 1994;
Ramaswamy et al., 2004). In brief, the continuity equation and the fully, time
dependent, 3-D Navier-Stokes equations (inertial frame of reference) for an
incompressible viscous fluid are:
∇.V = 0

Eq. 91

∂V/∂t + (V.∇)V = -1/ρ(∇p)+ ν∇2V

Eq. 92

Where, V is the velocity vector, p is the pressure, t is the time, ρ is the fluid
density, and ν is the kinematic viscosity. To permit motion, the ALE formulation
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introduces a grid velocity (Vg) in equations 1 and 2 to impose an additional
geometric constraint which is expressed in integral form as:
d/dt∀d∀ = sVg.ds

Eq. 93

Note that Vg is known a priori which in our case was identified as we have
previously reported by us (Salinas et al., 2012; Salinas et al., 2014b), as follows:
The FSF bioreactor specimens were assumed to take on a parabolic shape and
fit to the equation of an arc, given by:
.

√ +

=

Eq. 94

Where b is the new position of the moving post as it moves to the stationary post
and C is the nonlinear parabolic constant. The specimen length was fixed at 17
mm. The constant, “C” was computed numerically (Mathcad® v.15, PTC,
Needham, MA) over the 250 time steps. The continuity and momentum
equations with Vg incorporated can be re-expressed as:
d/dt∀ρd∀ + sρ(V – Vg) .ds = 0
d/dt∀ρVd∀ + sρ V(V – Vg) .ds = s σij.ds

Eq. 95
Eq. 96

Where, ∀ is the arbitrarily moving control volume, S is the surface of ∀, and σij is
the second order stress tensor. With Vg now known, we wrote a script interfaced
to the main CFD software (CFX, Ansys Inc.), such that a numerical solution could
be computed at a given temporal position, for the moving mesh.
In addition to satisfying the convergence criteria (1 x 10-9) for the
momentum and continuity equations, the final solution convergence was
accomplished once the mesh displacement equations also satisfied the
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prescribed residual value of 1x10-9. We note that for the dynamic simulations
cyclic independence was achieved in the second cycle from which the results
were analyzed, since a less than 5% difference was found when comparing the
average specimen shear stress between the 2nd and 3rd cycles.
4.2.6 Validation Studies
4.2.6.1 CFD Simulation of a moving indentation in a 2-D Channel
Pedley and Stephanoff (Pedley and Stephanoff, 1985) conducted an in
vitro experiment aimed at understanding the incompressible fluid flow through
collapsible tubes such as arteries and veins. In their experiment, A 100mm x
100mm plate was pushed into a Poiseulle laminar flow, creating vortices. The
total length and height of the channel was 410 mm, and 10 mm, respectively.
Vortex characteristics were governed by the Strouhal and Reynolds numbers in
addition to the degree of indentation.

Figure 15. Schematic representation of the 2-D channel used in the experiment.
Source: Lai Y.G., and Przekwas A.J., (1994). A Finite-Volume Method for Fluid
Flow Simulations with Moving Boundaries. Computational Fluid Dynamics,
Volume 2., pp. 19-40.
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The motion of the wall is governed by the following 2-D Cartesian equations:
Y(x) = h
Y(x) = 0.5h {1-th [a(x-x2)]}
Y(x) = 0

Eq. 97

for 0<x<x1
for x1<x<x3
for x>x3

Eq. 98
Eq. 99

Where a = 4.14 cm;
h = 0.5hmax [1-cos(2πt*)]

Eq. 100

t* = t-to/T, hmax=0.38, T = 5.33 (s)

Eq. 101

The Reynolds number (Re) based on the inlet bulk velocity (U) and channel width
(b) was Re= 507. The Struohal number (St) was St = b/UT = 0.037.
Here we demonstrated that the CFD engine from CFX ® (Ansys,
Canonsburg, PA) can calculate the flow physics shown in the visualization
experiments (Pedley and Stephanoff, 1985). A fully structured mesh of the
channel was created comprising of 20,000 elements as seen in Figure 16. The
mesh after the deformation can be observed in Figure 17. In the simulations, the
inlet velocity was 65.789 mm/sec, density was set to 1000 kg/m3, viscosity was
1.079x10-3 Pa.s, and the time step used was 0.01 sec. Using the equations that
govern the plate displacement, we implemented a moving boundary simulation.
They reported the results as a function of normalized time where 0 was the
beginning of the cycle and 1 was the end of the cycle. One cycle was equal to 4
seconds. The time steps specified was t* = 0.01. The simulation was run during
four cycles to allow for periodicity.
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Figure 16. CFD Mesh – 20,000 Hexagonal Elements. 0 seconds (undeformed).

Figure 17. CFD Mesh – 20,000 Hexagonal Elements.
Pedley and Stepanoff (Pedley and Stephanoff, 1985) observed that the
flow was unidirectional for the first 0.34 normalized time. At 0 the experiment
showed a single recirculation region. Existence of multiple eddies where reported
in following times as shown in Figure 18. CFD velocity vector plots are shown in
Figure 19 where it can be seen that CFX ® (Ansys, Canonsburg, PA) was able to
precisely replicate the flow vortices observed during the flows visualization
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experiments performed by Pedley and Stephanoff (Pedley and Stephanoff,
1985).

Figure 18. Simplified sketch of the flow patterns observed by (Pedley and
Stephanoff, 1985). Source: Pedley T.J. and Stephanoff K.D., (1985), Flow along
a Channel with a Time-Dependent Indentation in One Wall: the Generation of
Vorticitv Waves. Journalof Fluid Mechanics, Volume 160, pp.337-367.
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A 0.34
B 0.41
C 0.48
D 0.55
E 0.62
F 0.69
G 0.76
H 0.84
I 0.91

Figure 19. CFD replication of flow experiments performed by (Pedley and
Stephanoff, 1985).
4.2.6.2 CFD validation of specimen dynamic simulations
We compared our shear stress results (time step = 2 ms) for our flex-flow
simulations with a similar dynamic simulation (time step = 0.5 ms) conducted by
Ramaswamy et al. (Ramaswamy et al., 2014) which employed a custom-written
code based on the immersed boundary method and utilized a sample with
dimensions of 1mm x 7 mm x 25 mm. In this study, our sample utilized
dimensions of 1mm x 6.5 mm x 17 mm. Our results for shear stress were found
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compliance with acceptable convergence of the governing equations in the CFD
studies we performed.
Going back to the study that utilized the IBM to resolve the flow field in the
FSF, u-shaped bioreactor (Ramaswamy et al., 2014) we strongly believe that the
10% difference in shear stresses that was found compared to our corresponding
simulation was mainly due to the differences in sample dimensions and the time
steps between the two investigations. Nonetheless, we state that the simulations
performed by (Ramaswamy et al., 2014) were highly precise while comparatively,
the ones conducted in this study were still within a reasonable degree of
accuracy (10%) and could thus be used to evaluate relative flow physics among
the different bioreactor CFD simulations conducted (e.g. combined cyclic
specimen flexure and steady flow versus cyclic flexure-alone).
4.3 Results
The fluid-induced, time averaged axial shear stresses were plotted on the
inner and outer surfaces for all the simulation cases (Figure 20). The values were
found to be higher on the outer wall for all cases except the control (no flow, no
flexure) wherein they were essentially the same on both walls. The highest shear
stress values were observed to occur at the vertex of the samples. This finding is
consistent with the previous report by (Engelmayr et al., 2008). In addition, the
prediction of amplified wall shear stresses at the vertex of the samples was
indicated in (Engelmayr et al., 2006) as a potential mediator of tissue formation.
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Also, the flex-flow simulations showed augmented shear stresses relative
to steady flow-alone or specimen cyclic flexure-alone.

Outer wall
Inner wall

Outer wall

Control
Inner wall
Steady flow-alone
straight
Steady flow- alone
semi-bent
Steady flow-alone
fully-bent
Cyclic
flexure-alone
Flex-flow
Flow direction

Time averaged axial shear stress (Pa)
-0.05

0.12

0.3

Figure 20: Fluid-induced, time-averaged axial shear stresses over one cycle on
specimen inner and outer walls for the following six cases: i) no flow and no
flexure ii) steady flow-alone (straight sample), iii) steady flow-alone (semi-bent
sample), iv) steady flow-alone (fully-bent sample), v) cyclic flexure-alone and vi)
flex-flow states. Shear stresses were found to be higher along the outer wall
except in the case of no flow and no flexure. The highest shear stresses were
observed around the vertex of the sample. In comparing the two dynamic cases
(v) versus (vi), the flex-flow state displayed much higher shear stress values.
To observe the velocity profiles at a section surrounding the vicinity of the
samples, a longitudinal cross-sectional plane (x= 0.0175 m) at the center line of
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the specimens was applied (Figure 21). The results showed non-existent to
modest levels of flow separation in the steady flow-alone cases; when the
samples were straight the flow was fully unidirectional in the forward flow
direction (Figure 21a). On the other hand, a few vortices proximal to the inner
specimen wall were observed in the semi-bent and fully bent configurations.
Substantially higher flow reversal regions were observed in the case
involving cyclic flexure-alone (Figure 21b). Complete recirculation zones
occurred simultaneously with the initiation of sample bending (t = 0 s). Loss of
uniformity in the size and pattern of vortices in the flow field increased at
subsequent time steps. In addition, the velocity streamlines were different during
the bending (t = 0.25 s) and unbending (t = 0.75 s) events, even though the
sample configurations at these time instances were identical. Meanwhile, in the
flex-flow case (Figure 21c), the number of flow vortices increased with the
specimen flexure states but was not as pronounced as those observed in
comparison to cyclic flexure-alone (Figure 21b). On the other hand, in the flexflow environment, there was greater variability in the axial velocity distribution.
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a) Steady flow-alone
Straight
Semi-bent
Fully-bent
b) Cyclic flexure-alone

c) Flex-flow

t= 0 s
t= 0.25 s
t= 0.5 s
b

t= 0.75 s
t= 1 s

Axial velocity (m/s)

Flow direction

-0.08

0

0.08

Figure 21: Contour of velocity magnitudes and velocity streamlines in the plane
(x= 17.5 mm) surrounding the specimens for the following cases: a) steady flowalone (straight sample), b) cyclic flexure-alone and c) flex-flow states. The inlet
velocity for a) and c) was set to 0.022 m/s while for b) it was set to 0 m/s. A large
degree of vortices formed in cyclic flexure-alone case, but the magnitude of
velocity field was clearly lower when compared to steady flow-alone and flex-flow
cases. It was also noted that the flow physics during the specimen flexing and
straightening events (in both b) and c) at the instance when the specimen shape
was identical, i.e., at t =0.25 and 0.75 s respectively were not the same.
In order to quantify the extent of directionality changes in the temporal
shear stress experienced by the samples, i.e., OSS under cyclic flexure-alone
and flex-flow conditioning, the oscillatory shear index (OSI) was calculated. As
previously defined by He and Ku (He and Ku, 1996) the equation for the OSI is
given by:
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=

( −

Where, abs(

(

)
( )

Eq. 102

τdt) is the magnitude of the time-averaged shear stress while

abs(τ)dt is the time-averaged shear stress magnitude. One can observe that:
0.0 ≤ OSI ≤ 0.5, where an OSI = 0.0 represents unidirectional flow while OSI =
0.5 signifies complete oscillatory flow.
Consistent with the axial velocity plots (Figure 21), the OSI distribution
was found to be much higher when exposed to cyclic flexure-alone, relative to
flex-flow conditions (Figure 22a). The area averaged OSI on the specimen inner
walls (n=3) was 0.433 and 0.230 for cyclic flexure-alone and flex-flow cases
respectively while the corresponding values for the outer wall (n=3) was found to
be 0.313 and 0.076. For the dynamic simulations, as a means to represent the
coupled effects of shear stress magnitude and OSS, we defined the product of a
specimen’s OSI distribution and its corresponding time averaged shear stress
magnitude (TSSM), multiplied by a factor of two, as the “OSI-scaled shear stress
magnitude” (OSI-| |), i.e.,:
OSI-| | = 2 * OSI * TSSM

Eq. 103

The OSI-| | distribution was in general, relatively higher on the specimen
surfaces (Figure 22b) under flex-flow states compared to cyclic flexure-alone.
The area averaged OSI-| | for the inner walls were 0.01 Pa (cyclic flexure-alone)
and 0.066 Pa (flex-flow) while for the outer walls these were 0.016 Pa (cyclic
flexure-alone) and 0.028 Pa (flex-flow).
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Outer wall
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flexure-alone

OSI
Flex-flow
Inner wall

Inner wall
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Outer wall
→

b)

osi − τ

Inner wall

Outer wall
→

osi − τ

Flow direction
0

0.12
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0.24

Figure 22: a) OSI on the inner and outer specimen surface for the dynamic cyclic
flexure-alone and flex-flow cases. The node averaged OSI along the inner walls
were 0.433 (cyclic flexure-alone) and 0.230 (flex-flow) while for the outer walls
the OSI was 0.313 (cyclic flexure-alone) and 0.076 (flex-flow). b) OSI-scaled
shear stress magnitude (osi-| |) on the inner and outer specimen surface for the
dynamic cyclic flexure-alone and flex-flow cases. The node averaged osi-| |
along the inner walls were 0.01 Pa (cyclic flexure-alone) and 0.066 Pa (flex-flow)
while for the outer walls the osi-| | was 0.016 Pa (cyclic flexure-alone) and 0.028
Pa (flex-flow). Effectively the osi-| | metric served to combine both the time
averaged and oscillatory shear stress components, demonstrating that its
magnitude was much lower in cyclic flexure-alone states compared to flex-flow
states, even though the OSI of the former was substantially higher compared to
the latter.
Previously, Engelmayr et al. (Engelmayr et al., 2006) defined a percent
increase in collagen content relative to the average collagen content of the no
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flow, no flexure (control group), steady flow-alone, cyclic flexure-alone and flexflow groups. When plotting the TSSM, OSI and OSI-| | metrics as a function of
these previously reported collagen content amounts, only OSI-| | was found to
be in direct proportion to the substantially augmented engineered collagen that
had formed when cyclic flexure and steady flow conditions were combined
(Figure 23). In a similar fashion, we quantified the net % increase in the mean
TSSM, OSI and OSI-|τ| parameters that resulted from flex-flow mechanical
conditioning in comparison to the sum of the corresponding parameter amounts
resulting from cyclic flexure-alone and steady flow-alone conditioning, as follows:
%

=

(

) (

)
)

(

Eq. 104

where “Parameter” Refers to TSSM, OSI or OSI-|τ|. The % increases for TSSM,
OSI and OSI-|τ| were found to be, 27.65%, -37.19%, and 207.14% respectively.
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Figure 23: For the following three cases of 1) steady flow-alone (straight sample),
2) cyclic flexure-alone and 3) flex-flow states, the specimen area mean: a)
TSSM, b) OSI and c) OSI-| | was plotted vs. the percentage (%) collagen
increase. In a) b) and c), the % increase in collagen was observed relative to the
average of the sum of no flexure and no flow, steady flow-alone (straight sample)
and cyclic flexure-alone, as previously reported by (Engelmayr et al., 2006) Only
the OSI-| | parameter demonstrated a convincing correlation to the collagen
production found in flex-flow states (Engelmayr et al., 2006), which resulted in
significantly higher engineered tissue collagen content.
4.4 Discussion
Shear stress is known to be an important promoter of engineered tissue
formation (Engelmayr et al., 2008; Engelmayr et al., 2006; Karim et al., 2006). In
addition to the magnitude of these stresses, studies have independently
suggested that temporal changes in the directionality of shear stress, i.e., OSS is
also critical for promoting tissue formation and phenotype (Li et al., 2004;

81

Ramaswamy et al., 2010). For example, the importance of OSS has directly been
associated with the regulation of the KLF2-a gene which is essential for normal
valvulogenesis (Vermot et al., 2009).
In this study we sought to computationally simulate the localized flow
physics surrounding engineered tissue specimens that could have ultimately
been responsible for the significant increases in collagen tissue production
reported in previous heart valve tissue engineering investigations, under the
combination of steady flow and sample cyclic flexure (Engelmayr et al., 2006).
Thus, in this investigation, we simulated, no flow-no flexure (control) , steady
flow-alone, cyclic flexure-alone and flex-flow conditions of samples that
underwent mechanical conditioning in a bioreactor; to incorporate the bending
motion of the samples, the cyclic flexure-alone and flex-flow simulations both
required moving boundary computational simulations which we implemented
using the ALE formulation.
Previously Engelmayr et al. (Engelmayr et al., 2008) predicted that the
peak wall shear stress magnitudes on rectangular-shaped specimens occurred at
the upstream, convex edge of the flexed samples and approached 1 Pa, while
the corresponding average value was 0.182 Pa. In this study, the peak wall shear
stress magnitude was found to be 0.30 Pa, occurring at the same spatial location
on the specimens (specimen vertex along the outer wall, steady flow-alone, fullybent case; Figure 20), while the average wall shear stress magnitude was 0.05
Pa. As observed in both current and previous investigations (Engelmayr et al.,
2008) on conditioned rectangular-shaped, flexed specimens, the peak specimen
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shear stress magnitudes were roughly five to six times higher than the average.
However, the shear stress magnitudes in the current study were much lower than
those reported by Engelmayr et al. (Engelmayr et al., 2008) primarily because of
the relatively lower inlet velocity boundary condition that was prescribed (0.022
m/s here versus 0.08 by (Engelmayr et al., 2008). Our inlet velocity was based
on the time-averaged flow conditions of the human pulmonary artery (Lotz et al.,
2002).
The major novelty of our study is that we identified a new biomechanical
parameter in the form of a scaled OSI (OSI-|τ|) that correlates with the previously
reported observation (Engelmayr et al., 2006) that, greatly augmented
engineered collagen formation occurred solely when steady flow and cyclic
flexure were combined, i.e. the flex-flow state. On the other hand, neither TSSM
nor OSI alone could convincingly explain the large increases in collagen content
derived from this flex-flow activity.
Clearly OSI-| | yielded a much higher value, roughly 7.5 times larger than
the percent increase in TSSM alone (Figure 23a). On the other hand, any
correlation with OSS proved to be incorrect since the combined flex-flow states
suggested less engineered collagen content relative to the cyclic flexure-alone
case (Figure 23b). We believe that the reason for this was because, while
specimen cyclic flexure-alone is highly effective at generating OSS (Fig 17a), it is
obviously not accompanied by appreciable shear stress magnitudes, which are
typically facilitated by a flow source, such as a pump. Specifically, the case of
cyclic flexure-alone comprises of relatively low magnitudes of fluid shear stress
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arising only from the motion of the cyclically flexing specimens in an effectively
static fluid bath. Clearly, this is an example of a mechanical conditioning
environment of relevance to heart valve tissue engineering where the OSS is
high but the shear stresses are low, which previously led to insignificant levels of
engineered tissue content, relative to no flow, no flexure static controls
(Engelmayr et al., 2006). This observation demonstrates yet again that the coexistence of both metrics, i.e., OSS and TSSM are important for engineered
collagen formation.
The % increase reported by Engelmayr et al. (Engelmayr et al., 2006) in
engineered collagen production under flex-flow states compared to the average
collagen content of the no flow, no flexure, steady flow-alone and cyclic flexurealone conditions was 75% whereas the corresponding increase for the sum of
independent cyclic flexure-alone and steady flow-alone was only 42%. Similarly,
the OSI-| | quantity under flex-flow states was 0.044 Pa while the corresponding
value for the sum of independent cyclic flexure-alone and steady flow-alone was
0.014 Pa. In other words, significant increases in engineered collagen content
under flex-flow states correlated with an appreciable, corresponding increase in
the OSI-|τ| parameter (Figure 23c).
The goal of the OSI-|τ| parameter is to emphasize that BOTH the timeaveraged shear stress magnitude (TSSM) and OSI are important in promoting
engineered heart valve tissue formation as was previously observed in the
experiments of Engelmayr et al. (Engelmayr et al., 2006). As a result we define
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OSI-|τ| as a single index that can capture the necessity for both OSI and TSSM
metrics to be present during heart valve tissue engineering experiments. A factor
of two is multiplied in the definition of OSI-|τ| for the following reason: When the
OSI is maximum, i.e., OSI = 0.5, the OSI-|τ| simply reduces to TSSM. On the
other hand, as one would observe during steady flow-alone or cyclic flexurealone mechanical conditions, OSI-|τ| would be zero and negligible respectively.
We note again that the findings of Engelmayr et al. (Engelmayr et al., 2006)
suggested that neither steady flow-alone or cyclic flexure-alone showed any
significant augmentation in engineered collagen formation compared to static
tissue culture (no flow-no flexure, control group). Therefore indeed, in these
cases, we would expect that the biomechanical conditioning “effect” of OSI-|τ| to
be zero or negligible. Thus, we have in a simple way shown that neither TSSM
nor OSI alone can convincingly explain significant increases in collagen
production that Engelmayr et al. (Engelmayr et al., 2006) reported under a
combination of flex-flow states. On the other hand, the combination of these two
parameters, characterized by OSI-|τ| does capture the synergy of the flex-flow
state (in the context of promoting engineered collagen production activity). In the
flex-flow case the average specimen OSI was not a maximum of 0.5 but was
instead found to be ∼ 0.23. Thus, the OSI-|τ| parameter served to reduce the
mechanical conditioning “effect” of TSSM, by a factor of 0.46 (i.e., 2 * OSI), in the
flex-flow case.
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We note however that OSI-|τ| needs to be interpreted in a relative rather
than an absolute context, for example in comparing flex-flow versus steady flowalone or versus cyclic flexure-alone. Certainly the magnitude of TSSM and OSI
can have independent effects on the amount of engineered tissue formation.
However, this amount when obtained from a steady flow-alone (TSSM-only) or
cyclic flexure-alone (OSI-only) experiment will always be small relative to a
corresponding experiment conducted under flex-flow states (both TSSM and OSI)
which utilizes the same magnitude of TSSM and OSI as when they were used
independently. In addition, in this first approximation study, the OSI-|τ| metric
also assumed that both OSI and TSSM are equally important, although this
remains to be proven. Finally, since the Engelmayr et al. (Engelmayr et al., 2006)
study was based on bone marrow stem cells (BMSCs) the interpretation of OSI|τ| can for the time-being only be used for this cell type since the response of
other cell types to mechanical stimuli and subsequent rates of engineered
collagen synthesis may be different. We believe nonetheless that this distinction,
i.e., OSI-| | is important (as opposed to simply TSSM alone or OSS alone). This
is because OSS can be generated without a flow source and purely through
specimen movement, while non-moving specimens exposed to a steady flow
source that generate physiological-levels of shear stresses are not exposed to
oscillatory effects; yet the simultaneous presence of shear stress magnitude and
temporal changes to the directionality in flow seem to be required to promote
engineered heart valve tissue formation.
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In conclusion, we present a modification of the traditional OSI parameter
first defined by He and Ku (He and Ku, 1996), by multiplying it to its spatially
corresponding time-averaged, fluid-induced shear stress quantity (TSSM) and by
a factor of two. In doing so, we were able to demonstrate that the combination of
both parameters (OSI-| |) correlated strongly with the greatly augmented
engineered collagen production reported from previous in vitro experiments
(Engelmayr et al., 2006), under flex-flow conditioning regimens. We wish to
emphasize however, that a limitation of our study was that the OSI-| | metric we
defined assumed that both OSI and TSSM are equally important, but this may or
may not be the case and remains to be determined. Our principal goal behind
OSI-| | was to demonstrate that both the magnitude and directionality (i.e.,
oscillations) of the fluid-induced shear stresses are critical in augmenting tissue
formation, rather than to arrive at a precise metric that can be used to quantify
the relative contributions of OSI and TSSM. Indeed as stated earlier, our
definition of OSI-| | is by no means an ideal metric and remains at best, a crude
approximation. Nonetheless, in this particular study OSI-| | did correlate with
increased collagen formation. However given that there is a dependence on the
biological response of different cell types to mechanical environments, the
correlation could be altered if cells other than BMSCs are used in the tissue
engineering experiments.
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CHAPTER 5: MASS TRANSPORT MODEL
The most severe forms of congenital heart disease have an incidence rate
of ∼ 20,000 live births/year (Hoffman, 1995). A large number of these cases
present with problems associated with the heart valves. Moreover, an estimated
104,000 valve procedures are performed in the US (Roger et al., 2011) alone
annually and this number continues to grow each year. Today, replacement of a
defective valve with a prosthetic heart valve is commonplace in adult and
pediatric patients. However, despite recent advances in medical technology,
distinct limitations remain in the current treatment of critical, congenital heart
valve disease. Even though prosthetic valves are currently used to replace
defective valves, no currently available treatment option provides a permanent
solution. Among the pediatric population, the situation is further aggravated by
the inability of the valve substitute to permit somatic growth thus necessitating
the child to undergo multiple invasive operations. From a research standpoint,
functional, organ-level, tissue engineered heart valve (TEHV) replacement which
would permit somatic growth and would not pose any immune risks was thought
to represent the Holy Grail in treating valve disease. For example, extensive work
in the heart valve tissue engineering area has been conducted by the Mayer and
Hoerstrup groups (Hoerstrup et al., 2000a; Hoerstrup et al., 2000b; Hoerstrup et
al., 1998; Hoerstrup et al., 1999; Sodian et al., 2000a; Sodian et al., 1999;
Sodian et al., 2000b; Sodian et al., 2000c). They showed that when implanted in
the pulmonary artery position, TEHVs functioned (observed for four months) in
growing lambs, exhibiting durability, growth, and lack of thrombogenicity
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(Hoerstrup et al., 2000a; Sutherland et al., 2005). Yet, after more than a decade
of intensive TEHV investigations which included clinical studies (Dohmen et al.,
2011), identification of a specific protocol for optimized construct development
which can subsequently be clinically translated remains elusive. While potential
cell sources and scaffold materials for heart valve tissue engineering have been
identified (Chen and Wu, 2005; Fong et al., 2006; Frank et al., ; Hilfiker et al.,
2011; Kadner et al., 2002; Leor et al., 2005; Lichtenberg et al., 2006; Martinez et
al., 2013; Neuenschwander and P. Hoerstrup, 2004; Perry et al., 2003; Schmidt
et al., 2006; Schmidt et al., 2010; Siepe et al., 2008; Simon et al., 2006; Weber et
al., 2011a; Weber et al., 2011b), the biomechanical conditions needed to
promote the heart valve phenotype still require further investigation. In addition,
cellular responses to the applied mechanical stresses will undoubtedly depend
on the cell type(s) being utilized; adult progenitor cells, such as bone marrow
derived stem cells (BMSCs) are deemed likely candidates for utility in heart valve
tissue engineering owing to their pluripotency, ease of access and lack of ethical
concerns. Given that valvulogenesis is closely tied to its surrounding
hemodynamics, it has been generally accepted that this biomechanical
environment to the extent possible, be recapitulated during engineered heart
valve tissue culture. However, the specifics such as the manner in which
mechanical stresses need to be applied, the necessity to deform the growing
construct similar to a native valve and the duration of the culture process remain
uncertain.
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To further understand in vivo native heart valve stress environments,
several efforts have focused on the innate stresses that native heart valves are
subjected to, namely, fluid-induced shear stresses and the cyclic tissue stretch
and flexure events that occur during valve opening and closure. Specifically,
custom-made heart valve bioreactors have been used to study the individual or
combined effects of these stresses on engineered tissue formation (Engelmayr et
al., 2003; Engelmayr et al., 2008; Ramaswamy et al., 2014; Ruel and Lachance,
2009), while computer simulations have focused on the quantification of stress
states on valvular tissues (Engelmayr et al., 2008; Ramaswamy et al., 2014;
Salinas et al., 2014a; Salinas et al., 2014b; Salinas and Ramaswamy, 2014;
Stella et al., 2007). Some of the key mechanobiological findings were as follows:
Engelmayr et al (Engelmayr et al., 2006) showed that BMSCs cultured under
conditions of flow and scaffold flexure produced more collagen than conditions of
flow or cyclic flexure-alone. Vermot et al. (Vermot et al., 2009) reported that
oscillatory shear stresses (OSS) directly regulated the gene klf2a which is
required for normal valve development. We previously showed (Salinas and
Ramaswamy, 2014) that robust collagen production from the combination of
cyclic flexure and steady flow states (flex-flow) (Engelmayr et al., 2006) was a
direct result of an appreciable shear stress magnitude tied to a high degree of
flow oscillations, i.e., OSS. Moreover we also demonstrated that these types of
OSS environments can be recreated under pulsatile flow conditions wherein the
samples are fixed, i.e., do not move (Salinas et al., 2014a; Salinas et al., 2014b).
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The specific biomechanical environments used in the culture of
engineered heart valve tissues will contribute towards the transport of nutrients
and removal of metabolic waste products from the growing constructs (Brown et
al., 2007; Chen et al., 2014; Ramaswamy et al., 2014; Salinas and Ramaswamy,
2014; Syedain, 2009b). Such transport is critical to the survival of cells, their
phenotypic stability and subsequently the robustness of extracellular matrix that
is produced. Indeed it has been shown that without adequate, homogeneous
delivery of nutrients within cultured tissues, cell and matrix content will be
adversely affected (Wang et al., 2008; Wang et al., 2011), with an overall
decrease in the rate of its production.
Although mass transport in tissue culture involves multiple biochemical
species, studies focused on other tissue types, such as skin, cartilage, oculartissues, and blood vessels have clearly established the importance of adequate
oxygen (Abraham et al., 2013; Ai and Vafai, 2006; Chung and Vafai, ; Chung and
Vafai, 2013; de Monte et al., 2013; Denny and Walsh, ; Ethier and Moore, 1997;
Gill et al., 2011; Johnson et al., 2009; Kaazempur-Mofrad et al., 2005; Karner
and Perktold, 2000; Khakpour and Vafai, 2008; Kumar et al., 2004; Liu et al.,
2011; Prosi et al., 2005; Stangeby and Ethier, 2002; Tarbell et al., 1988; Wang et
al., 2009) and glucose delivery. (Boubriak et al., 2006; Converti et al., 1996; Day
et al., 2013; Gao and Xu, 2011; Koutny, 2011a; Koutny, 2011b; Martineau, 2012;
Mokhbi Soukane et al., 2007).
Biochemical species is supplied to living tissues viatwo mechanisms: the
first is convective mass transport while the second is through diffusive processes
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(Stangeby and Ethier, 2002; Yang and Vafai, 2006). Convective nutrient delivery
is associated with pressure-driven transmural flow while the diffusive process is
initiated by species-specific concentration gradients (Ai and Vafai, 2006; Ethier
and Moore, 1997). These gradients are caused by nutrient consumption and
production of metabolic wastes by the cells embedded within the tissues (Chung
and Vafai, ). Mass transport models thus far have focused primarily on studying
the distribution of oxygen in heart valve tissues due to convection and diffusion
(Brown et al., 2007; Chen et al., 2014; Liu et al., 2011; Wang et al., 2008; Wang
et al., 2011). However, they were limited to simplified diffusion models or did not
account for oxygen consumption rates by cells. Moreover heart valve tissue
engineering protocols typically employ a mechanical conditioning protocol
wherein a flow and/or specimen movement (e.g. cyclic flexure) component is
present (Engelmayr et al., 2006; Ramaswamy et al., 2010) the convectivediffusive processes that occur in these settings have thus far not been identified,
but may play a critical role in maintaining construct viability for subsequent
implantation.
From a biomechanics standpoint, we recently identified (Salinas and
Ramaswamy, 2014) that measurable quantities of fluid-induced stresses
accompanied by an oscillatory component were strongly correlated to the
significantly higher collagen content found in constructs that were subjected to
the combination of steady flow and specimen cyclic flexure (flex-flow) (Engelmayr
et al., 2006). However, since these samples were moving, the enhanced tissue
production may not have been due to only biomechanical effects; rather, the
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evolution of de novo tissues in dynamic culture systems involving conditions such
as flex-flow may also be modulated by the efficiency of the mass transport
mechanism(s). Therefore in this study, we built on our previous computational
fluid dynamics (CFD) models (Salinas and Ramaswamy, 2014) to include mass
transport components, specifically in the delivery of glucose and oxygen to the
growing 3-dimensional (3D) engineered tissues. We correlated these findings
with literature in vitro experiments (Engelmayr et al., 2006).
5.1 Methods
5.1.1 Geometry, Mesh, and Simulation Set-up
We modeled the FSF bioreactor previously described in (Ramaswamy et
al., 2014; Salinas and Ramaswamy, 2014). We created a high density mesh of
the fluid domain of the bioreactor as previously reported in (Salinas and
Ramaswamy, 2014) with additional 4.5x104 tetrahedral elements in the sample
region as seen in Figure 24 and imported it into the CFD solver.(CFX version,
Ansys Inc., Canonsburg, PA). We replicated the simulations from (Salinas and
Ramaswamy, 2014) where we analyzed cases of flow-alone, sample cyclic
flexure-alone, flow and flexure, and a control group. The inlet boundary
condition was set to a velocity of 0.02 m/s for the cases of flex-flow and flowalone, and it was set to a velocity of zero for cases of cyclic flexure-alone and
control. No slip conditions were prescribed to the bioreactor walls while a porous
fluid-interface was set to the surface of the samples. All simulations were run
utilizing a Newtonian, viscous model, with laminar flow conditions with the
following fluid material properties: density = 1.01g/cm3 and dynamic viscosity =
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1.27 cp which were previously measured for regular cell culture basal media
(Ramaswamy et al., 2014). The outlet of the bioreactor was set to a zero relativepressure boundary condition. The housed bioreactor specimens were assumed
to have a constant, homogeneous porosity that were saturated with cell culture
medium. The cell density prescribed was 17x106cells/cm2 (Engelmayr et al.,
2006). The rectangular sample dimensions (L X W X t) were as follows: 17mm x
6.5 mm x 1mm equal to a total sample surface area of 2.68 cm2. This
represented a total number of cells of 4.556x107 in the surfaces on the
rectangular samples. The results were analyzed after a convergence criteria of
1x10-9 set for each of the momentum, continuity, mesh displacement, and mass
transport equations were satisfied. Simulations were conducted in a Hewlett
Packard work station with intel(R) Xeon(R) CPU, x5550@ 2.67GHz (2
processors) with 16.0 GB installed memory and 64-bit windows 7 operating
system.
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Walls

No slip conditions

Inlet

Plug velocity 0.02 m/s

Outlet

Outlet-Relative Pressure = 0 Pa

Samples

Porous-fluid Interface

Table 2. Boundary conditions used for the CFD transport model

a)

b)

c)

Figure 24: a) Depiction of the entire fluid domain of the bioreactor chamber. Note
the three scaffolds in a straight configuration and the plane (in red) at x =
0.0175m corresponding to the longitudinal center line of the samples. b) Cross
section (x =0.0175m) of the mesh. Note that the element density is higher inside
the samples in order to better capture mass transport events. c) A close-up of the
mesh around a single sample.
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5.2 Convective-diffusive model
Here, we built on this system by coupling the momentum transport
(Salinas and Ramaswamy, 2014) to a convective and diffusion mass transport
model which can provide information on glucose and oxygen-species distribution
within the housed bioreactor specimens over time and accounts for
physiologically valid glucose and oxygen cell consumption rates. The model is
characterized by the following equations:
+
∗

=

=

(

−
)

∗

=

Mackie and Meares Relation
Michaelis-Menten Relation

≪
=−

Where C β is the concentration of the solute in the medium; Φ is the fluid volume
fraction; γ is the sieving coefficient in a porous material; qβ is the source term for
generation, consumption or degradation of solute mass; vf is the velocity of the
fluid phase; Dβ is the effective diffusive coefficient in the porous medium; ρ cell is
the density of cell seeded in the scaffold; V β is the maximum uptake rate, K

is

the concentration at half velocity. The diffusivity in the fluid was prescribed to be
5.40x10-6 cm2/s for glucose and 5.40x10-6 cm2/s for oxygen (Das, 2007).
Meanwhile, the diffusivity in the scaffold was set to be 1.08x10-6 cm2/s and
0.60x10-5 cm2/s for glucose and oxygen respectively (Das, 2007). Finally, the
glucose consumption rate was set to 3.83x10-16 mole/cell.s, while oxygen was
assumed to be consumed at a rate of 3.75x10-17 mole/cell.s (Das, 2007).
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Property

Glucose

Oxygen

Diffusivity in Fluid cm2/s

5.40x10-6

3.00x10-5

Diffusivity in scafffold cm2/s

1.08x10-6

0.60x10-5

Metabolism rate in cell mole/cell.s

3.83x10-16

3.75x10-17

Metabolism rate in cell grams/cell.s

6.90 x10-14

6.00x10-16

Total Metabolism rate in sample g/s

-3 x10-06

-2.7335 x10-08

Table 3. Parameters used in the mass transport model.
5.3 Porosity and Mass Fraction
In order to determine the porosity of the PLA/PGA scaffold we first
measured its dry mass (WS). Then, the scaffold was submerged in water. After
that we recorded the weight of the water and the scaffold (WG). The weight of the
residual water (WGl) was also recorded after the scaffold was removed from the
container.
The void volume was given by
=
was given by

=

and the total volume was

. Where ρw is the density of water; the porosity of the sample
∗ 100. The porosity of the scaffold before any cell culture

experiments was ~ 95%. After the cell culture experiments the scaffold showed a
porosity of 75%. Glucose and Oxygen mass fractions in media were computed
based on the glucose concentration in cell culture media (DMEM, fisher sci,
pittbsurgh, PA) and from the ideal gas law respecitvely. The mass fraction of
glucose was found to be 0.0045, whereas for oxygen it was 0.00013.
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5.4 Results
As observed in Figures 25-29, the flow physics surrounding the
engineered tissue constructs resembled those previously described in (Salinas
and Ramaswamy, 2014). Briefly, flow was unidirectional during steady flow
conditions acting on straight specimens and minor flow changes were observed
on cases of steady flow and sample semi bent and fully bent configurations. Flow
vortices were observed at the beginning of the bending cycle in cases of cyclic
flexure-alone and they showed displacement and size changes at subsequent
time steps. Similar events where observed during conditions of flow and sample
flexure but with lower magnitude of events.
Flex-flow
t= 0 s
t= 0.25 s
t= 0.5 s
t= 0.75 s
t= 1 s
Axial velocity (m/s)

Flow direction
-0.017

0.0165

0.05

Figure 25. Contour of velocity magnitudes and velocity streamlines in the plane
(x= 17.5 mm) surrounding the specimens during flex-flow states

98

Cyclic flexure-alone
t= 0 s
t= 0.25 s
t= 0.5 s
t= 0.75 s
t= 1 s
Axial velocity (m/s)

Flow direction
-0.017

0.0165

0.05

Figure 26. Contour of velocity magnitudes and velocity streamlines in the plane
(x= 17.5 mm) surrounding the specimens during cyclic flexure-alone states.

Steady flow-alone
straight
Steady flow-alone
semi-bent
Steady flow-alone
fully-bent
Axial velocity (m/s)

Flow direction
-0.017

0.0165

0.05

Figure 27. Contour of velocity magnitudes and velocity streamlines in the plane
(x= 17.5 mm) surrounding the specimens during steady flow-alone states.
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Velocity (m/s)

0.023

Time averaged axial velocity - inner wall

0.018
0.013
0.008
0.003
-0.002 0

0.005

0.01

0.015

Outer wall

Distance (m)

Flow direction
Inner wall
Figure 28. Time averaged axial velocities (plane x = -0.0175 m) from line at
0.00015m below the inner wall.
Time averaged axial velocity - outer wall

Velocity (m/s)

0.023
0.018
0.013
0.008
0.003
-0.002 0

0.005

0.01

0.015

Distance (m)

Flow direction

Figure 29. Time averaged axial velocities (plane x = -0.0175 m) from line at
0.00015m above the outer wall.
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Normalized mass fractions of glucose and oxygen were high at high
porosities as seen in Figures 30-31. This is the norm for samples with porosity
greater than forty percent. Approximately at forty percent porosity the mass
fractions begin to decrease, and it is significantly lower at low sample porosities
such as ten or five percent. There is no presence of mass fraction in samples
that are fully solid (no porosity).
At 75% porosity levels, there was no significant glucose mass fraction
differences among cases of flex-flow, cyclic flexure-alone, flow-alone, and
control. It can be observed in Figure 32 that the glucose mass fraction ranged
from 0.967 to 0.991; analysis of variances shows no differences among groups at
a significant level of p = 0.05. The oxygen mass fraction ranged from 0.978 to
0.999 as shown in Figure 33. Analysis of variances shows no differences among
groups at a significant level of p = 0.05.
Normalized mass fraction contour along the center of the sample are
shown in Figure 34. It can be seen that in the case of glucose, there is good
uniformity in mass distribution along the center of the sample matrix. There is
highest presence of glucose in the flex-flow case, followed by the cyclic flexurealone case. Next were the flow cases which showed very similar mass profiles
among them. The lowest presence of mass was seen in the control group.
Similar scenarios were observed for the normalized mass transport of oxygen as
seen in Figure 35.
At sample porosities of 5%, there was significant glucose mass fraction
differences among cases of flex-flow, cyclic flexure-alone, flow-alone, and
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control. It can be observed in Figure 36 that the glucose mass fraction ranges
from 0.144 to 0.002; analysis of variances revealed that all groups are different
from each other at a significant level of p = 0.05 with the exception that the flowalone groups did not show significant differences among them. The oxygen
mass fraction ranges from 0.224 to 0.003 as seen in Figure 37. Analysis of
variances revealed that all groups are different from each other at a significant
level of p = 0.05 with the exception that the flow-alone groups did not show
significant differences among them.

Time Avg glucose normalized mf

Porosity vs time averaged mf
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0

20

40
60
Percent porosity (%)
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Figure 30. Time averaged normalized mass fraction for glucose at different
porosity percentages.
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Figure 31. Time averaged normalized mass fraction for oxygen at different
porosity percentages.
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Figure 32. At 75% porosity: Area and time averaged normalized mass fraction at
sample longitudinal wall at x = -0.0175m for glucose.
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Figure 33. At 75% porosity: Area and time averaged normalized mass fraction at
sample longitudinal wall at x = -0.0175m for oxygen.
Center wall (plane at
x = -0.175 m)
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Time averaged normalized
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fully-bent
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Figure 34. At 5% porosity: Time averaged normalized glucose mf (sample
longitudinal wall at x = -0.0175m) for cases of flex-flow, cyclic flexure-alone,
steady flow-alone and control.
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Figure 35. Time averaged normalized oxygen mf (sample longitudinal wall at x =
-0.0175m) for cases of flex-flow, cyclic flexure-alone, flow-alone and control.
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Figure 36. At 5% porosity: Area and time averaged normalized mass fraction at
sample longitudinal wall at x = -0.0175m for glucose.
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Figure 37. At 5% porosity: Area and time averaged normalized mass fraction at
sample longitudinal wall at x = -0.0175m for oxygen.
ANOVA
Normalized Glucose

Between Groups
Within Groups
Total

Sum of
Squares
.001
.001
.002

df

Mean Square
5
12
17

.000
.000

F
2.298

Sig.
.110

Table 4. At 75% porosity: Anova results for normalized glucose.
ANOVA
Normalized oxygen

Between Groups
Within Groups
Total

Sum of
Squares
.001
.001
.002

df

Mean Square
5
12
17

.000
.000

F
1.379

Table 5. At 75% porosity: Anova results for normalized glucose.
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Sig.
.299

ANOVA
Normalized glucose

Between Groups
Within Groups
Total

Sum of
Squares
.032
.000
.033

df

Mean Square
5
12
17

.006
.000

F

Sig.

642.116

.000

Table 6. At 5% porosity: Anova results for normalized glucose.
Multiple Comparisons
Dependent Variable: Normalized glucose
Tukey HSD
(I) Case
(J) Case
Mean
Difference (I-J)

flex-flow

Cyclic flexurealone

steady flow-alone
straight

steady flow-alone
semi-bent

steady flow-alone
fully-bent

control

Cyclic flexure-alone
steady flow-alone straight
steady flow-alone semi-bent
steady flow-alone fully-bent
control
flex-flow
steady flow-alone straight
steady flow-alone semi-bent
steady flow-alone fully-bent
control
flex-flow
Cyclic flexure-alone
steady flow-alone semi-bent
steady flow-alone fully-bent
control
flex-flow
Cyclic flexure-alone
steady flow-alone straight
steady flow-alone fully-bent
control
flex-flow
Cyclic flexure-alone
steady flow-alone straight
steady flow-alone semi-bent
control
flex-flow
Cyclic flexure-alone
steady flow-alone straight
steady flow-alone semi-bent
steady flow-alone fully-bent

.0583826663*
.0868963553*
.0870845327*
.0879335993*
.1419857773*
-.0583826663*
.0285136890*
.0287018663*
.0295509330*
.0836031110*
-.0868963553*
-.0285136890*
.0001881773
.0010372440
.0550894220*
-.0870845327*
-.0287018663*
-.0001881773
.0008490667
.0549012447*
-.0879335993*
-.0295509330*
-.0010372440
-.0008490667
.0540521780*
-.1419857773*
-.0836031110*
-.0550894220*
-.0549012447*
-.0540521780*

Std. Error
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427
.0025959427

Sig.
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
1.000
.998
.000
.000
.000
1.000
.999
.000
.000
.000
.998
.999
.000
.000
.000
.000
.000
.000

Table 7. At 5% porosity: Multiple comparisons using Tukey’s test for normalized
glucose.
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ANOVA
Normalized oxygen
Sum of

df

Mean Square

F

Sig.

Squares
Between Groups

.082

5

.016

Within Groups

.004

12

.000

Total

.085

17

55.448

.000

Table 8. At 5% porosity: Anova results for normalized oxygen.

Multiple Comparisons
Dependent Variable: Normalized oxygen
Tukey HSD
(I) Case

(J) Case

Mean

Std. Error

Sig.

Difference (IJ)
.1000000000*

.0140037338

.000

.1494511033

*

.0140037338

.000

.1494511033

*

.0140037338

.000

.1494511033

*

.0140037338

.000

.2209281770

*

.0140037338

.000

*

.0140037338

.000

.0494511033

*

.0140037338

.037

.0494511033

*

.0140037338

.037

.0494511033

*

.0140037338

.037

.1209281770

*

.0140037338

.000

-.1494511033

*

.0140037338

.000

-.0494511033

*

.0140037338

.037

steady flow-alone semi-bent

.0000000000

.0140037338

1.000

steady flow-alone fully-bent

.0000000000

.0140037338

1.000

*

.0140037338

.003

-.1494511033

*

.0140037338

.000

-.0494511033

*

.0140037338

.037

steady flow –alone straight

.0000000000

.0140037338

1.000

steady flow-alone fully-bent

.0000000000

.0140037338

1.000

*

.0140037338

.003

*

.0140037338

.000

Cyclic flexure-alone
steady flow-alone straight
flex-flow

steady flow-alone semi-bent
steady flow –alone fully-bent
control
flex-flow

Cyclic flexurealone

-.1000000000

steady flow-alone straight
steady flow-alone semi-bent
steady flow-alone fully-bent
control
flex-flow

steady flow-alone
straight

Cyclic flexure-alone

control

.0714770737

flex-flow
steady flow-alone
semi-bent

Cyclic flexure-alone

control

.0714770737

steady flow –alone flex-flow

-.1494511033
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fully-bent

-.0494511033*

.0140037338

.037

steady flow-alone straight

.0000000000

.0140037338

1.000

steady flow-alone semi-bent

.0000000000

.0140037338

1.000

*

.0140037338

.003

-.2209281770

*

.0140037338

.000

Cyclic flexure-alone

-.1209281770

*

.0140037338

.000

steady flow –alone straight

-.0714770737*

.0140037338

.003

steady flow-alone semi-bent

-.0714770737

*

.0140037338

.003

steady flow-alone fully-bent

-.0714770737*

.0140037338

.003

Cyclic flexure-alone

control

.0714770737

flex-flow
control

Table 9. At 5% porosity: Multiple comparisons using Tukey’s test for normalized
oxygen.

5.5 Discussion
Previously, we computationally investigated the effects of sample
movement on the flow physics surrounding tissue engineered constructs (Salinas
and Ramaswamy, 2014). We virtually replicated the experimental set up of a
particularly relevant in vitro heart valve tissue engineering experiment conducted
by Engelmayr et al. (Engelmayr et al., 2006) where rectangular PLA/PGA nonwoven, fibrous scaffolds seeded with BMSCs where mechanically conditioned in
a FSF bioreactor. They showed that cyclic specimen flexure combined with a
steady flow source greatly augmented engineered collagen production when
compared to cases of cyclic flexure-alone or steady flow-alone. Our previous
computational findings (Salinas and Ramaswamy, 2014) led us to note that a
combination of shear stress magnitude and oscillatory shear stress directly
correlated with collagen augmentation while each parameter on its own could not
explain greater tissue formation. In addition, sample flexure may have enhanced
nutrient delivery of glucose and oxygen through the walls of engineered
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constructs and into the cells and tissues thereby adding in the process of tissue
production.
In this study, we sought to computationally determine if, in addition to OSI| | (Salinas and Ramaswamy, 2014), mass transport of glucose and oxygen
played a role in augmented tissue formation reported in the in vitro flex-flow case
(Engelmayr et al., 2006). We incorporated a convective-diffusive mass transport
model (Das, 2007; Sengers et al., 2005) to our previously validated CFD
simulations where we looked at cases of flex-flow, cyclic flexure-alone, flowalone and controls. We elected this mass transport model because it provided
with mass concentration of glucose and oxygen species resulting from
convective and diffusive activity over time anywhere in the bioreactor and it used
physiologically valid cell consumption rates of both species.
Tissue culture and mathematical based studies have clearly established
the importance of adequate oxygen (Kumar et al., 2004; Wang et al., 2008) and
glucose delivery (Boubriak et al., 2006; Converti et al., 1996; Mokhbi Soukane et
al., 2007) for adequate cell activity and tissue formation and noted that any
unmet demand of nutrients can lead to low cell proliferation, and low collagen
production particularly at the center of scaffolds with low porosities (Ishaug-Riley
et al., 1998; Patnaik et al., 2013).
Some studies have reported that scaffolds used for tissue engineering
experiments have porosity as low as 73% (Yu et al., 2009) after cell and tissue
culture. During an in-house in vitro experiment, we determined that the porosity
of the 50:50 PLA/PGA scaffold was 95% before culture and 75 % porous after
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tissue culture experiments. Our simulations showed that there is adequate
delivery of both glucose and oxygen at high specimen porosities ranging from
forty percent porosity and higher (Figure 30-31). We confirmed this observation
by performing an anova test which showed no difference in the mass fraction of
glucose and oxygen during cases of flow, flexure and both combined. These
results suggest that sample cyclic flexure does not enhance nutrient delivery to
the center of engineered tissue constructs because diffusivity effects dominate
when scaffolds have high porosities, which is usually the norm for tissue
engineering studies that started tissue culture experiments with a highly porous
specimen (Yu et al., 2009). We note however that at low sample porosities (5%),
our simulations do show that sample movement enhanced nutrient delivery as
shown in figures 34-37 and validated by an anova study (Table 8-9). Although
low porosities are unlikely to be seen in tissue engineering studies, we
acknowledge that in some cases such as using decellularized scaffolds with high
ECM content low porosities can be observed and sample movement should be
highly considered in order to enhance nutrient transport. In addition, studies
using scaffolds with high thickness such as whole organ development may also
benefit from scaffold bending modes.

CHAPTER 6: PRELIMINARY EXPERIMENTAL OBSERVATIONS FOR OSI-| |
6.1 Introduction
We have computationally shown by an initial approximation given as OSI| | that both OSI and TSSM combined correlated with significantly higher
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engineered collagen production during modes of sample cyclic flexure combined
with a steady flow source. The OSI-| | was defined as twice the product of the
TSSM and the OSI. In previously resolved simulations (Salinas et al., 2014a;
Salinas et al., 2014b), we noted that oscillatory shear environments can be
maximized by a pulsatile flow source passing by straight static specimens. We
believe that the OSI-| | parameter is also present in significant magnitude when
flat specimens are subjected to physiologically valid pulsatile flow conditions and
that OSI-| | is responsible for inducing higher cell proliferation, gene expression
and tissue formation. In this study, we performed 2D in vitro cell culture
experiments where we subjected BMSCs seeded in straight surfaces to
conditions of physiologically valid pulsatile flow conditions and steady state flow
conditions. We conducted cell proliferation and gene expression assays and
determined if pulsatility environments enhanced these traits. In addition, we
performed a CFD simulation that replicated this in vitro experiment in order to
delineate and quantify OSI, TSSM, and OSI-| | parameters. Finally, we wanted
to correlate these parameters with results from the cell proliferation and gene
expression assays.
6.2 Methodology for Cell Culture experiments
6.2.1 Cell Differentiation: BMSCs were cultivated in T-75 flasks in a 37oC
incubator until 100% confluence was obtained, and were subsequently divided to
obtain a cell density of 17x106 cells/cm2 and cultured for an additional week. The
no flow (control) group (n=4) was cultured in the Bioflux 200 system (Fluxion
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Biosciences, San Francisco, CA) system without any flow sources. The steady
flow group (n=4) was cultured in the Bioflux 200 system and exposed to a steady
flow source capable of inducing an averaged shear stress of 1.5dyn/cm2. The
pulsatile flow group was cultured in the Bioflux 200 system and exposed to a
pulsatile shear stress obtained from a physiological pulmonary artery waveform
(Lotz et al., 2002).
6.2.2 Culture Media: The culture media contained DMEM High glucose
(Invitrogen, Carlsbald, CA), 10% fetal bovine serum (ATCC, Manasas, VA), 1%
antibiotic/antimycotic, 1% HEPES (Invitrogen, Carlsbald, CA), 2ηg/mL of basic
fibroblast growth factor (bFGF, Invitrogen, Carlsbald, CA), 82µg/mL Ascorbic
Acid (Sigma-Aldrich, St. Louis, MO). Media changes were performed every 24
hours for a period of one week. The amount of media added to each well for the
24-microfluidic well plate in the bioflux system was 3ml for the 96-well plate was
200µL for the controlgroup. The media contained 82µg/mL of Ascorbic acid.
6.2.3 Bioflux 200 System: The Bioflux 200 system comprises of a pneumatic
pump, a 24-microfluidic well plate, a 24-well plate interface, and a user operated
software. It permits mechanical conditioning of rectangular channels seeded with
cells by inducing steady or pulsatile flow conditions The Bioflux 200 is
connected to a microscope with a CCD camera allowing the user to take
photographs of the cultured cells under flow. This system is efficient for stem cell
applications, such as cell differentiation and gene expression.
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6.2.4 Assays:
Cell Differentiation-RNA Isolation and Reverse Transcription: SMCs were
washed with PBS and detached from the T-75cm2 flask (Fisher Scientific, PA) by
0.25%Trypsin-EDTA (ATCC, Manasas, VA). Then, the detached cells were
collected in a 15 ml conical tube (Fisher Scientific, PA). For the RNA isolation
procedure, the cells were transferred to a 1.5 ml RNAase free tube. Purification
of mRNA was performed through the SV Total RNA Isolation System (Promega,
Madison, WI). We conducted Reverse transcription reaction on 1µg of total
mRNA with GoScript™ Reverse Transcription System (Promega, Madison, WI).
The detection process was achieved through a Step One Real-Time PCR
System (Applied Biosystems, Carlsbad, CA). The cycling parameters were 950C,
5 seconds; 600C, 45 seconds; 950C, 15 seconds.
6.2.5 CFD Simulations
Using Ansys™ commercial software (Ansys Inc, Canonsburg, PA), the fluid
domain of the rectangular bioflux channel was constructed. The structured
mesh was composed of one million elements. Physical properties for bioreactor
media were used with density = 1.01 g cm3 and dynamic Viscosity = 1.27
centipoise. At the inlet, a physiologically valid velocity waveform (Lotz et al.,
2002) was imposed (Figure 38). The outlet was set to 0 relative pressure and all
walls were set to no-slip conditions. Simulations were run in a Hewlett
Packard™ work station with intel(R) Xeon(R) CPU, x5550@ 2.67GHz
(2processors) with 16.0 GB installed memory and 64-bit windows 7 operating
system. Independence tests were performed on mesh, time step, and
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periodicity for steady and pulsatile simulations accordingly. We monitored the
area averaged wall shear stress on the surface, and a 5% error acceptance
criterion in comparison with highly resolved simulations was used. All
simulations converged to 10-9. We computed oscillations in the flow by using the
OSI parameter described by He and Ku (He and Ku, 1996) and the OSI-|τ|
parameter as described by (Salinas and Ramaswamy, 2014).
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Velocity waveform
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Figure 38. Velocity waveform with a velocity average of 0.199386 cm/s. It was
used as the inlet velocity for the transient pulsatile simulations at 2 millisecond
intervals.
6.2.6 Statistics
We performed analysis of variance tests in order to determine if the significant
differences between control, steady flow and pulsatile flow groups. We used
Tukey’s test with a significance of p = 0.05. Normality distributions and equal
variance were assumed.
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6.3 Results
6.3.1 In vitro Experiments
In Figures 39-56 it we showed a section of the channel where the cells are
attached to the walls. During cell seeding, the shape of the cells was mainly
rounded and began to elongate in the following days. In the case of the steady
flow, cells showed a slight formation in the flow axial direction. This event was
also seen in the pulsatile flow group, but with less intensity than the steady flow
case. Both steady and pulsatile groups showed higher number of cells attached
to the walls when compared to the control group. Cells counts for each group
were conducted and reported in Figure 57. Indeed, we observed that there were
more cells in the pulsatile flow group followed by the steady flow case, and the
control group, respectively. We performed an anova study which determined that
there are significant differences between the means of these groups as shown in
Table 10. At a significance of p = 0.05, Tukey’s test revealed that there are no
significant differences between the three groups when compared to each other
seen in table 11.

Figure 39. Control group. Cell attached to the walls of the bioflux 200 system day
1.
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Figure 40. Control group. Cell attached to the walls of the bioflux 200 system day
5.

Figure 41. Control group. Cell attached to the walls of the bioflux 200 system day
6.

Figure 42. Control group. Cell attached to the walls of the bioflux 200 system day
7.
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Figure 43. Steady flow group. Cell attached to the walls of the bioflux 200 system
day 1.

Figure 44. Steady flow group. Cell attached to the walls of the bioflux 200 system
day 2.

Figure 45. Steady flow group. Cell attached to the walls of the bioflux 200 system
day 3.
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Figure 46. Steady flow group. Cell attached to the walls of the bioflux 200 system
day 4.

Figure 47. Steady flow group. Cell attached to the walls of the bioflux 200 system
day 5.

Figure 48 Steady flow group. Cell attached to the walls of the bioflux 200 system
day 6.
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Figure 49. Steady flow group. Cell attached to the walls of the bioflux 200 system
day 7.

Figure 50. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 1.

Figure 51. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 2.
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Figure 52. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 3.

Figure 53. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 4.

Figure 54. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 5.
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Figure 55. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 6.

Figure 56. Pulsatile flow group. Cell attached to the walls of the bioflux 200
system day 7.
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Figure 57. Bar chart showing the number of cells during control, steady, and
pusatile flow experiments.
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ANOVA
Cell Count
Sum of Squares

df

Mean Square

Between Groups
Within Groups

656472616.667
66853725.000

2
9

Total

723326341.667

11

F

328236308.333
7428191.667

Sig.

44.188

.000

Table 10. Anova results for cell count from control, steady and pulsatile flow
conditions
Multiple Comparisons
Dependent Variable: Cell Count
Tukey HSD
(I) Flow
(J) Flow

No flow
Steady flow
Pulsatile flow

Steady flow
Pulsatile flow
No flow
Pulsatile flow
No flow
Steady flow

Mean Difference
(I-J)
*

-5457.50000
-17690.00000*
5457.50000*
-12232.50000*
17690.00000*
12232.50000*

Std. Error

1927.19896
1927.19896
1927.19896
1927.19896
1927.19896
1927.19896

Sig.

.047
.000
.047
.000
.000
.000

95% Confidence Interval
Lower Bound
Upper
Bound
-10838.2503
-76.7497
-23070.7503 -12309.2497
76.7497 10838.2503
-17613.2503 -6851.7497
12309.2497 23070.7503
6851.7497 17613.2503

Table 11. Post hoc tests. Multiple comparisons using Tukey’s test for cell counts
from control, steady and pulsatile flow conditions.
Figures 58-60 indicate gene expression of BMSCs when exposed to
control, steady flow and pulsatile flow environments, respectively. The graph was
normalized to GAPDH. In the control group there was strong expression of
GAPDH and B-integrin genes. Also, there was weak expression of PECAN-1 and
VE-Cadherin genes. In the steady flow group there was strong expression of
GAPDH and B-integrin PECAN-1 and VE-Cadherin genes. In the pulsatile flow
group there was strong expression of GAPDH and B-integrin, Thy-1, and Tie-1
genes. Also, there was weak expression of PECAN-1, VE-Cadherin, and FLK-1
genes.
Previously computed OSI contours (Rath et al., 2014) are shown in figure
61a. In can be seen that there was high oscillatory shear environments acting on
the walls of the channels seeded with BMSCs. The area averaged OSI was 0.49.
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In this study we also reported on the TSSM that the walls were exposed to, and it
is shown in Figure 61b. The area averaged TSSM was 197 Pa. Finally, we
computed the OSI-| |, shown in Figure 61c. The area averaged OSI-| | was 195
Pa. Due to the high OSI values, the OSI-| | values approximate to the time
averaged shear stresses per our definition of OSI-| | (Salinas and Ramaswamy,
2014), which was our original intent when defining it in this manner.
Genes expressed after no flow conditions
10

0.1

0.001

Figure 58. Genes expressed after control conditions.
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TIE-1

FLK-1

THY-1

VE_CAD

PECAN-1

B-int

GAPDH

0.00001

Genes expressed after steady flow conditions
10

0.1

0.001

TIE-1

FLK-1
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VE_CAD

PECAN-1

B-int

GAPDH

0.00001

Figure 59. Genes expressed after steady flow conditions.
Genes expressed after pulsatile flow conditions
10

0.1

0.001

Figure 60. Genes expressed after pulsatile flow conditions.
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Figure 61. Contours of a) OSI (Rath et al., 2014) , b) Time averaged shear
stress, and c) OSI-| | of the bioflux 200 rectangular channel seeded with BMSCs.
6.4 Discussion
OSI-| | computationally obtained by (Salinas and Ramaswamy, 2014) has
been linked to promote engineered collagen formation by BMSCs in vitro heart
valve tissue engineering experiments (Engelmayr et al., 2006). However, OSI-| |
has not been associated to increase BMSCs proliferation or gene expression. In
this study we decided to conduct a preliminary in vitro experiment where BMSCs
where exposed to cell culture environments where OSI-| | can be maximized
within physiologically valid ranges. Previously, we reported that oscillatory shear
environments can be maximized by using a physiologically derived pulsatile flow
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source acing on straight static specimens (Salinas et al., 2014a; Salinas et al.,
2014b). We noted that this set up should also have high OSI-| | values, which
encouraged us to seed BMSCs in perfectly flat rectangular cell culture channels
in a bioflux200 system (Fluxion Biosciences, San Francisco, CA) and expose
them to pulsatile flow.
We computationally simulated the experimental set up in Ansys CFX
(Ansys, Canonsburg, PA) and found that indeed OSI-| | strongly acted on the
surfaces of the BMSCs seeded channels as seen in Figure 60c. Given the high
degree of oscillations in the wall shear direction (Figure 61a), the OSI-| | closely
resembled the TSSM values (Figure 61b). We note that in the control and steady
flow cases, there was no presence of OSI-| | values given that they are not time
dependent scenarios. OSI-| | was only present in the pulsatile case. There was
significantly (p<0.05) higher number of cells in the pulsatile case when compared
to the control and steady flow cases (Table 11). In addition, there was significant
(p>0.05) differences between the control and steady group. This finding suggests
that while shear stress along does mildly influence cell proliferation when acting
alone, when accompanied by oscillatory shear environments there is enhanced
BMSCs proliferation.
We considered genetic markers for smooth muscle cells (SMCs)
particularly integrin, beta1, THY-1, FZD2, and MLC1F. We also studied
endothelial cell (ECs) genes comprising PECAN-1, FLK1, and VE-cadherin.
Gene expression assays revealed that all groups had strong presence of GAPDH
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B-int, PECAN1, and VE-cadherin genes with the exception that the control group
showed weak presence of Pecan-1 and VE-cadherin as seen in Figure 58-60. In
addition, the pulsatile case group showed strong presence of Thy-1 and Tie-1
genes and significant presence of Flk-1 gene when compared to control and
steady groups which did not account for these genes. In brief, B-int (integrin
beta1) is involved in cell adhesion, tissue repair, and embryogenesis; THY-1
regulates adhesion, migration, and fibrosis cell- cell, and cell–matrix interactions.
PECAM1 participates in leukocyte migration, angiogenesis, and integrin
activation. FLK1 is a signaling protein for vascular endothelial growth factor; TIE1
regulates cell adhesion molecules. Lastly, VE-cadherin participates in
angiogenesis (Martinez et al., 2013).
Importantly, Thy-1 has been shown to be present in undifferentiated stem
cells (Martinez et al., 2013). Thus as a preliminary experimental finding, we have
found here through increased Thy-1 expression from oscillatory flow conditions,
that BMSCs remain in a less differentiated state. This has important implications
from a heart valve tissue engineering stand point as a TEHV could benefit from
the plasticity of cell lineages during in vitro studies using heart valve like
geometries or after in vivo implantation. Further studies to confirm BMSC-based
gene expression outcomes under different flow states are ongoing by other
investigators in our laboratories.
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CHAPTER 7: CONCLUSIONS, LIMITATIONS, FUTURE WORK
In this study we developed moving boundary CFD simulations to study the
effects of movement of engineered tissue constructs on the flow physics and
mass transport. In addition, we correlated the computational results with
engineered collagen formation, cell proliferation and cell phenotype from
literature and in-house in vitro experiments. We presented a modification of the
traditional OSI parameter (He and Ku, J. Biomech Eng., 1996) given by: OSI-| |
= 2 * OSI *

( )

and demonstrated that the OSI-| | correlated strongly

with the greatly augmented engineered collagen production reported from
previous in vitro experiments (Engelmayr et al., 2006), under flex-flow
conditioning regimens.
We presented a convective-diffusive mass transport model to study sample
movement effects on mass transport of glucose and oxygen. We found that
sample flexure of 75% porous scaffolds did not enhance mass transport of
glucose and oxygen, but sample flexure of 5% porous scaffolds did enhance
mass transport of glucose and oxygen. We noted that in tissue engineered
studies, sample porosity ranges from 92-0.73% porosity (Yu et al. Int J. Heat
&Mass transfer, 2009). This suggests that mass transport did not enhance tissue
production reported in (Engelmayr et al., 2006). We reported that mass transport
of glucose and oxygen is independent of specimen shape as seen by the flowalone cases with straight, semi-bent and fully bent sample geometries. We note
that in this particular study, the initial definition of OSI-| |(Salinas and
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Ramaswamy, J. Biomech, 2014) was the only fluid induced parameter that
correlated with augmented tissue formation by BMSCs. We computationally
showed that OSI-| | environments can be maximized during conditions of high
oscillatory shear caused by physiologically valid pulsatile flow conditions (Figure
61). In an effort to observe to effect of OSI-| | on cell proliferation and cell
phenotype, we conducted an in vitro experiment where BMSCs implanted on cell
culture channels in a bioflux200 where exposed physiologically valid pulsatile
conditions. We showed that OSI-| | environments up-regulated cell differentiation
and cell phenotype. We thus recommend that heart valve tissue engineering
protocols utilize physiologically valid pulsatile flow sources to mechanically
condition, by means of OSI-| | environments, BMSCs implanted in rectangular
cell/tissue culture environments as it has been shown to play a significant role in
tissue formation, cell proliferation and cell phenotype.
In this study, our mass transport model considered only two species:
glucose and oxygen. In addition, it only considered diffusivity effects in cell
culture media and scaffold matrix. Furthermore we did not consider any stretch
modes. Stretching of engineered tissue constructs may mediate BMSCs activity.
Our in vitro study was conducted in a 2-D set up and did not account for collagen
formation.
Future studies in our laboratories will be aimed at addressing the main
limitations described above. The mass transport model will be modified in order
to include cell specific permeability and account for more species including for
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example lactate and important growth factors. The 3-D in-house cell and tissue
culture studies will be performed using an FSF bioreactor containing BMSCs
seeded porous scaffolds fixed in a straight configuration. A physiologically valid
pulsatile flow source will be used to mechanically condition the engineered
constructs and the results of BMSC gene expression will be correlated to shear
stress and shear stress variants (e.g. OSI and OSI-| |).
As an initial effort, we have conducted the CFD simulations based on a
square pulsatile velocity waveform (Figure 62) that yielded 850 ml/min flow rate
used in similar bioreactor studies (Ramaswamy et al., 2014). We calculated the
TSSM, OSI and OSI-| | values for the three rectangular specimens, which are
shown in Figure 63. The area averaged values for the inner wall (n=3) were 0.15
± 0.011 Pa, 0.45 ± 0.023, 0.14 ±0.015 Pa for TSSM, OSI and OSI-| | ,
respectively. In the case of the outer wall, the area averaged values were 0.12 ±
0.012 Pa, 0.29 ± 0.019, 0.073 ± 0.002 Pa for TSSM, OSI and OSI-| | ,
respectively. Clearly, these CFD results (Figure 63a) show that relatively large
magnitudes of OSI-| | can be created through flow pulsatility on fixed, nonmoving
specimens. In other words, any effect by specimen movement to improve
engineered tissue formation and gene expression outcomes from BMSCs, via
altered mass transport mechanisms will be eliminated. Future bioreactor
experiments in our laboratories, in-line with these CFD simulations will delineate
if OSI-| | is the sole regulator of enhanced BMSCs gene expression and tissue
formation in the context of the heart valve phenotype.
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Figure 63. Contours of the inner and outer walls of the fixed rectangular
specimens for a) TSSM; b) OSI; c) osi-| |.
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